| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | BHLHE41 HDAC9 NCOA6 ZMYND8 MED14 GON4L SUPT20HL2 DCC ARID1A MIDEAS KAT2B MRTFB MED13 NPAT MED13L SIRT1 HIPK3 CCAR1 SMARCC2 YY1AP1 SPEN HCFC1 | 2.73e-06 | 562 | 251 | 22 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BHLHE41 HDAC9 TPR NCOA6 GATAD2A ZMYND8 LRRK2 MED14 GON4L SUPT20HL2 IRS1 DCC ARID1A WNK1 MIDEAS MEN1 MAGI2 KAT2B MRTFB SYNE2 FBXO7 MED13 NPAT MED13L SIRT1 HIPK3 MDC1 STON2 CCAR1 SMARCC2 YY1AP1 RPA1 SPEN HCFC1 | 3.73e-06 | 1160 | 251 | 34 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | BHLHE41 HDAC9 TPR NCOA6 GATAD2A ZMYND8 LRRK2 MED14 GON4L SUPT20HL2 IRS1 DCC ARID1A WNK1 MIDEAS MEN1 MAGI2 KAT2B MRTFB SYNE2 FBXO7 DLG1 MED13 NPAT MED13L SIRT1 HIPK3 MDC1 STON2 CCAR1 OTUD4 SMARCC2 YY1AP1 RPA1 SPEN CDH1 HCFC1 | 6.87e-06 | 1356 | 251 | 37 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription factor binding | BHLHE41 HDAC9 STK36 NCOA6 ZMYND8 MED14 SIK1 ARID1A TRIP12 PGR KAT2B TAF4 MED13 PCLO SIX1 SIRT1 PASD1 MTOR ARID2 IPO13 SPEN HCFC1 HTT | 8.38e-05 | 753 | 251 | 23 | GO:0008134 |
| GeneOntologyMolecularFunction | histone H3K14 deacetylase activity, hydrolytic mechanism | 1.57e-04 | 2 | 251 | 2 | GO:0031078 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | BHLHE41 HDAC9 ZMYND8 GON4L MIDEAS NPAT SIRT1 HIPK3 CCAR1 YY1AP1 SPEN | 1.60e-04 | 229 | 251 | 11 | GO:0003714 |
| GeneOntologyMolecularFunction | histone H3K9 deacetylase activity, hydrolytic mechanism | 4.68e-04 | 3 | 251 | 2 | GO:0032129 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA6 MED14 DCC ARID1A KAT2B MRTFB MED13 NPAT SIRT1 CCAR1 SMARCC2 HCFC1 | 4.79e-04 | 303 | 251 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | SMAD binding | 7.55e-04 | 86 | 251 | 6 | GO:0046332 | |
| GeneOntologyMolecularFunction | histone H4K deacetylase activity | 9.29e-04 | 4 | 251 | 2 | GO:0141051 | |
| GeneOntologyMolecularFunction | histone H3K deacetylase activity | 9.29e-04 | 4 | 251 | 2 | GO:0141050 | |
| GeneOntologyMolecularFunction | histone H4K16 deacetylase activity, hydrolytic mechanism | 9.29e-04 | 4 | 251 | 2 | GO:0034739 | |
| GeneOntologyMolecularFunction | beta-1 adrenergic receptor binding | 9.29e-04 | 4 | 251 | 2 | GO:0031697 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | BHLHE41 HDAC9 TPR ZHX3 ZNF536 ZBTB38 HIVEP1 GATAD2A TRO ZMYND8 GON4L SIK1 ZNF318 ARID1A MIDEAS MYEF2 MEN1 KAT2B DLG1 NPAT FOXM1 NRIP2 ZBTB33 POU6F1 SIX1 ZHX2 SIRT1 PHC2 PASD1 HIPK3 TRIM33 CCAR1 SMARCC2 SIX5 ZFHX3 YY1AP1 SPEN HCFC1 | 3.23e-06 | 1399 | 253 | 38 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | BHLHE41 HDAC9 TPR ZHX3 ZNF536 ZBTB38 HIVEP1 GATAD2A TRO ZMYND8 GON4L SIK1 ZNF318 ARID1A MIDEAS MYEF2 MEN1 KAT2B DLG1 NPAT FOXM1 NRIP2 ZBTB33 POU6F1 SIX1 ZHX2 SIRT1 PHC2 PASD1 HIPK3 TRIM33 CCAR1 SMARCC2 SIX5 ZFHX3 YY1AP1 SPEN HCFC1 | 4.07e-06 | 1413 | 253 | 38 | GO:1902679 |
| GeneOntologyBiologicalProcess | DNA repair | HDAC9 EPC2 ZMYND8 SUPT20HL2 ARID1A TRIP12 MEN1 KAT2B UBR5 NFRKB TAF4 FOXM1 EP400 SMARCAL1 DCLRE1B SIRT1 RFWD3 ARID2 EEPD1 MDC1 OTUD4 SMARCC2 RPA1 | 5.48e-06 | 648 | 253 | 23 | GO:0006281 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | HDAC9 TPR EPC2 KMT2B GATAD2A TDRD9 LIN54 ZMYND8 MED14 ARID1A TRIP12 MEN1 KAT2B UBR5 NFRKB MLLT6 TAF4 GNAS BAHCC1 CENPT EP400 BICRA SMARCAL1 SIRT1 BAZ1A ARID2 MDC1 SMARCC2 RPA1 HCFC1 | 5.76e-06 | 999 | 253 | 30 | GO:0071824 |
| GeneOntologyBiologicalProcess | embryo development | NCOA6 GATAD2A SUPT20HL2 EXT2 ITGA4 ACVRL1 RRM2 ARID1A WNK1 TRIP12 MEN1 XYLT1 FREM2 KAT2B MRTFB SEC24B PTPRQ NFRKB DLG1 GNAS CNOT3 PRRC2B NPAT COL27A1 FLVCR1 EPB41L5 TNRC6C SIX1 COL18A1 IFT52 TENM4 ARID2 RPA1 CDH1 HCFC1 RAI2 HTT | 1.46e-05 | 1437 | 253 | 37 | GO:0009790 |
| GeneOntologyBiologicalProcess | chromatin organization | HDAC9 TPR EPC2 KMT2B GATAD2A TDRD9 LIN54 ZMYND8 ARID1A TRIP12 MEN1 KAT2B UBR5 NFRKB MLLT6 GNAS BAHCC1 EP400 BICRA SMARCAL1 SIRT1 BAZ1A ARID2 MDC1 SMARCC2 RPA1 HCFC1 | 1.64e-05 | 896 | 253 | 27 | GO:0006325 |
| GeneOntologyBiologicalProcess | DNA damage response | HDAC9 EPC2 NCOA6 ZBTB38 ZMYND8 SUPT20HL2 ARID1A TRIP12 MEN1 KAT2B UBR5 NFRKB TAF4 FOXM1 ATMIN EP400 SMARCAL1 GTSE1 DCLRE1B SIRT1 RFWD3 MTOR ARID2 EEPD1 MDC1 OTUD4 SMARCC2 RPA1 | 2.01e-05 | 959 | 253 | 28 | GO:0006974 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | TPR LRRK2 IRS1 PGR UBR5 CIZ1 FERMT2 POM121L2 SIX1 SIRT1 DCP1B MTOR IPO13 CDH1 HTT | 4.43e-05 | 362 | 253 | 15 | GO:0034504 |
| GeneOntologyBiologicalProcess | heart development | HDAC9 NCOA6 UBE4B SIK1 ITGA4 ACVRL1 ARID1A WNK1 FREM2 KAT2B MRTFB SEC24B ALPK3 FAT4 POU6F1 SIX1 RBM20 SIRT1 ADGRG6 IFT52 TENM4 MTOR ARID2 | 6.32e-05 | 757 | 253 | 23 | GO:0007507 |
| GeneOntologyBiologicalProcess | DNA metabolic process | HDAC9 EPC2 ZBTB38 ZMYND8 SUPT20HL2 ACVRL1 ARID1A TRIP12 LIN9 MEN1 KAT2B UBR5 NFRKB CIZ1 TAF4 FOXM1 EP400 WEE1 SMARCAL1 DCLRE1B SIRT1 RFWD3 BAZ1A ARID2 EEPD1 MDC1 OTUD4 SMARCC2 RPA1 | 6.57e-05 | 1081 | 253 | 29 | GO:0006259 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | BHLHE41 HDAC9 TPR ZHX3 ZNF536 HIVEP1 GATAD2A TRO ZMYND8 SIK1 ARID1A MYEF2 MEN1 KAT2B DLG1 FOXM1 NRIP2 ZBTB33 POU6F1 SIX1 ZHX2 SIRT1 HIPK3 TRIM33 SMARCC2 ZFHX3 SPEN HCFC1 | 1.03e-04 | 1053 | 253 | 28 | GO:0000122 |
| GeneOntologyBiologicalProcess | heterochromatin boundary formation | 1.50e-04 | 2 | 253 | 2 | GO:0033696 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | EPC2 SUPT20HL2 ARID1A KAT2B NFRKB TAF4 FOXM1 EP400 SIRT1 ARID2 SMARCC2 | 1.57e-04 | 234 | 253 | 11 | GO:0006282 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 1.70e-04 | 95 | 253 | 7 | GO:2000781 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | GATAD2A GON4L ARID1A NFRKB EP400 BICRA BAZ1A ARID2 SMARCC2 YY1AP1 | 2.21e-07 | 96 | 249 | 10 | GO:0070603 |
| GeneOntologyCellularComponent | chromatin | BHLHE41 EPC2 ZHX3 BNC2 GATAD2A STAG1 ZMYND8 GON4L SUPT20HL2 ARID1A PGR MEN1 KAT2B PRDM10 UBR5 NFRKB TAF4 FOXM1 ZBTB33 EP400 BICRA ADNP2 KLF15 POU6F1 SIX1 ZHX2 ATF6B SIRT1 PHC2 TRIM33 ATF6 ZFHX4 BAZ1A ARID2 SMARCC2 SIX5 ZFHX3 YY1AP1 HCFC1 | 2.38e-06 | 1480 | 249 | 39 | GO:0000785 |
| GeneOntologyCellularComponent | ATPase complex | GATAD2A GON4L ARID1A NFRKB EP400 BICRA BAZ1A ARID2 SMARCC2 YY1AP1 | 3.41e-06 | 129 | 249 | 10 | GO:1904949 |
| GeneOntologyCellularComponent | nuclear body | IL16 HIVEP1 CCNDBP1 GATAD2A STAG1 GON4L TRIP12 FASTK PLAG1 PLA2G6 NPAT ATMIN CENPT EP400 PNN KLF15 DCLRE1B SIRT1 RFWD3 PASD1 HIPK3 MTOR MDC1 LRCH4 ZFHX3 YY1AP1 RPA1 | 1.12e-05 | 903 | 249 | 27 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | HDAC9 TPR NCOA6 KMT2B GATAD2A LIN54 MED14 GON4L ARID1A MIDEAS MEN1 SYNE2 NFRKB TAF4 MED13 EP400 PNN BICRA RANBP3 SMARCAL1 POM121L2 MED13L ATF6B SIRT1 PHC2 PASD1 PCF11 ATF6 BAZ1A ARID2 INTS4 SMARCC2 YY1AP1 RPA1 HCFC1 | 1.80e-05 | 1377 | 249 | 35 | GO:0140513 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 3.12e-05 | 75 | 249 | 7 | GO:0035097 | |
| GeneOntologyCellularComponent | transcription repressor complex | 8.13e-05 | 87 | 249 | 7 | GO:0017053 | |
| GeneOntologyCellularComponent | transcription regulator complex | BHLHE41 HDAC9 NCOA6 GATAD2A LIN54 MED14 MIDEAS LIN9 MEN1 PRDM10 TAF4 SIX1 ATF6B PASD1 ATF6 ARID2 SIX5 ZFHX3 SPEN | 1.03e-04 | 596 | 249 | 19 | GO:0005667 |
| GeneOntologyCellularComponent | methyltransferase complex | 3.14e-04 | 108 | 249 | 7 | GO:0034708 | |
| GeneOntologyCellularComponent | INO80-type complex | 3.21e-04 | 28 | 249 | 4 | GO:0097346 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 4.22e-04 | 30 | 249 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 6.13e-04 | 33 | 249 | 4 | GO:0044665 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 9.14e-04 | 94 | 249 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | Ino80 complex | 1.00e-03 | 17 | 249 | 3 | GO:0031011 | |
| MousePheno | abnormal cardiovascular development | EPHX2 NCOA6 KMT2B GATAD2A SUPT20HL2 SSR1 ITGA4 ACVRL1 ARID1A WNK1 MRTFB UBR5 SEC24B PRRC2B NPAT FOXM1 ATMIN PNN FLVCR1 EPB41L5 KLF15 BCAR1 SIX1 SIRT1 ADGRG6 IFT52 ARAP3 ARID2 PEAK1 RAPGEF2 SPEN ATP2A2 | 2.70e-07 | 802 | 207 | 32 | MP:0002925 |
| MousePheno | abnormal prenatal growth/weight/body size | NCOA6 KMT2B GATAD2A STAG1 SUPT20HL2 IRS1 SSR1 ACVRL1 ARID1A WNK1 MIDEAS TRIP12 MEN1 UBR5 PRRC2C SEC24B DLG1 PLAG1 SUCO NOVA1 NPAT POMT2 ATMIN VPS37A PNN BICRA COL27A1 UBE3B EPB41L5 DCLRE1B BCAR1 MED13L SIX1 SIRT1 TRIM33 IFT52 ARAP3 TENM4 MTOR SMARCC2 CEP295 RAPGEF2 ATP2A2 HCFC1 HTT | 2.41e-06 | 1493 | 207 | 45 | MP:0004196 |
| MousePheno | abnormal embryonic growth/weight/body size | NCOA6 KMT2B GATAD2A STAG1 SUPT20HL2 SSR1 ACVRL1 ARID1A WNK1 TRIP12 MEN1 UBR5 PRRC2C SEC24B DLG1 PLAG1 POMT2 VPS37A PNN BICRA COL27A1 UBE3B EPB41L5 DCLRE1B BCAR1 MED13L SIX1 SIRT1 TRIM33 IFT52 ARAP3 TENM4 MTOR SMARCC2 CEP295 RAPGEF2 ATP2A2 HCFC1 HTT | 1.34e-05 | 1295 | 207 | 39 | MP:0002088 |
| MousePheno | edema | MAN2C1 KMT2B STAG1 UBE4B SSR1 WNK1 MRTFB GNAS PRRC2B NPAT FOXM1 ATMIN PNN BICRA COL27A1 FLVCR1 MED13L SIX1 SIRT1 ADGRG6 IFT52 ARID2 ATP2A2 | 1.71e-05 | 581 | 207 | 23 | MP:0001785 |
| MousePheno | abnormal extraembryonic tissue morphology | NCOA6 GATAD2A STAG1 SUPT20HL2 SSR1 ITGA4 ACVRL1 ARID1A WNK1 TRIP12 LIN9 MRTFB UBR5 SEC24B FHIP1A PRRC2B POMT2 COL27A1 GNPTAB EPB41L5 SIX1 DENND4C ADGRG6 TRIM33 IFT52 ARAP3 MTOR RAPGEF2 CDH1 HTT | 2.85e-05 | 908 | 207 | 30 | MP:0002086 |
| MousePheno | decreased cell proliferation | BHLHE41 NCOA6 CCNDBP1 STAG1 IRS1 ITGAD LIN9 PGR UBR5 FOXM1 ATMIN FAT4 WEE1 SMARCAL1 SUCNR1 SIX1 PHC2 HIPK3 ATF6 MTOR ARID2 CSPG4 MDC1 RAPGEF2 RPA1 HTT | 3.62e-05 | 739 | 207 | 26 | MP:0000352 |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | NCOA6 STAG1 UBE4B MIDEAS MEN1 MRTFB SEC24B FHIP1A FOXM1 ATMIN BICRA FLVCR1 DENND4C SPEN | 3.77e-05 | 263 | 207 | 14 | MP:0011099 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | NCOA6 KMT2B GATAD2A ITGA4 ACVRL1 ARID1A WNK1 TRIP12 MEN1 UBR5 TAF4 POMT2 EP400 PNN EPB41L5 BCAR1 ADGRG6 IFT52 ARAP3 TENM4 MTOR ARID2 RAPGEF2 CDH1 HTT | 4.05e-05 | 700 | 207 | 25 | MP:0011098 |
| MousePheno | abnormal visceral yolk sac morphology | SUPT20HL2 ACVRL1 ARID1A WNK1 MRTFB UBR5 SEC24B EPB41L5 DENND4C IFT52 ARAP3 RAPGEF2 CDH1 | 5.05e-05 | 236 | 207 | 13 | MP:0001718 |
| MousePheno | absent erythrocytes | 6.19e-05 | 6 | 207 | 3 | MP:0000215 | |
| MousePheno | increased mouth tumor incidence | 6.19e-05 | 6 | 207 | 3 | MP:0003750 | |
| MousePheno | abnormal oligodendrocyte physiology | 7.39e-05 | 16 | 207 | 4 | MP:0008917 | |
| MousePheno | abnormal fluid regulation | NCOA6 MAN2C1 KMT2B STAG1 UBE4B SSR1 ACVRL1 ARID1A WNK1 MRTFB UBR5 GNAS PRRC2B NPAT FOXM1 ATMIN PNN BICRA COL27A1 FLVCR1 MED13L SIX1 SIRT1 ADGRG6 IFT52 ARID2 ATP2A2 | 8.92e-05 | 826 | 207 | 27 | MP:0001784 |
| MousePheno | embryonic lethality during organogenesis | NCOA6 KMT2B GATAD2A STAG1 ITGA4 ACVRL1 ARID1A WNK1 TRIP12 MEN1 UBR5 TAF4 POMT2 EP400 PNN FLVCR1 EPB41L5 BCAR1 SIRT1 ADGRG6 IFT52 ARAP3 TENM4 MTOR ARID2 RAPGEF2 CDH1 HTT | 9.60e-05 | 876 | 207 | 28 | MP:0006207 |
| MousePheno | abnormal prenatal body size | NCOA6 GATAD2A STAG1 IRS1 SSR1 ARID1A MEN1 UBR5 PRRC2C SEC24B DLG1 PLAG1 SUCO NOVA1 POMT2 ATMIN VPS37A BICRA COL27A1 UBE3B EPB41L5 DCLRE1B SIRT1 TRIM33 IFT52 ARAP3 MTOR SMARCC2 CEP295 RAPGEF2 ATP2A2 HCFC1 HTT | 9.80e-05 | 1116 | 207 | 33 | MP:0010866 |
| MousePheno | abnormal blood vessel morphology | EPHX2 EPC2 NCOA6 GATAD2A STAG1 UBE4B SUPT20HL2 SSR1 ACVRL1 ARID1A WNK1 PGR MAGI2 PROM1 FREM2 MRTFB UBR5 SYNE2 SEC24B PRRC2B NPAT FOXM1 ATMIN SGIP1 COL27A1 FLVCR1 UBE3B GNPTAB KLF15 BCAR1 MED13L SIX1 COL18A1 ARAP3 ARID2 PEAK1 RAPGEF2 CDH1 ATP2A2 HTT | 1.05e-04 | 1472 | 207 | 40 | MP:0001614 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | STK36 BNC2 NCOA6 KMT2B STAG1 UBE4B NFASC SSR1 DCC ARID1A MIDEAS MEN1 MAGI2 MRTFB SEC24B FBXO7 DLG1 GNAS SUCO FHIP1A NOVA1 FOXM1 ATMIN FAT4 PNN BICRA COL27A1 FLVCR1 TNRC6C SIX1 SIRT1 DENND4C ZFHX4 SMARCC2 SPEN HTT | 1.06e-04 | 1269 | 207 | 36 | MP:0011111 |
| MousePheno | increased facial tumor incidence | 1.07e-04 | 7 | 207 | 3 | MP:0008018 | |
| MousePheno | abnormal cardiac muscle tissue morphology | HDAC9 NCOA6 UBE4B QRICH1 ACVRL1 ARID1A WNK1 MEN1 MRTFB ALPK3 FOXM1 KLF15 BCAR1 RBM20 SIRT1 ADGRG6 ARID2 ATP2A2 HCFC1 | 1.22e-04 | 489 | 207 | 19 | MP:0010630 |
| MousePheno | abnormal myocardium layer morphology | NCOA6 UBE4B QRICH1 ACVRL1 ARID1A WNK1 MEN1 MRTFB ALPK3 FOXM1 KLF15 BCAR1 RBM20 ADGRG6 ARID2 ATP2A2 HCFC1 | 1.46e-04 | 414 | 207 | 17 | MP:0005329 |
| MousePheno | abnormal heart layer morphology | NCOA6 UBE4B QRICH1 ACVRL1 ARID1A WNK1 MEN1 MRTFB ALPK3 FOXM1 KLF15 BCAR1 RBM20 ADGRG6 ARID2 ATP2A2 HCFC1 | 1.83e-04 | 422 | 207 | 17 | MP:0010545 |
| MousePheno | abnormal extraembryonic tissue physiology | NCOA6 SUPT20HL2 ITGA4 ACVRL1 WNK1 TRIP12 PGR UBR5 EPB41L5 ADGRG6 ARAP3 TENM4 RAPGEF2 CDH1 HTT | 1.95e-04 | 345 | 207 | 15 | MP:0004264 |
| MousePheno | dilated pharyngeal arch artery | 2.18e-04 | 2 | 207 | 2 | MP:0012494 | |
| MousePheno | hyperchromic macrocytic anemia | 2.18e-04 | 2 | 207 | 2 | MP:0008945 | |
| MousePheno | increased salivary adenocarcinoma incidence | 2.18e-04 | 2 | 207 | 2 | MP:0000621 | |
| MousePheno | abnormal heart septum morphology | QRICH1 SSR1 ARID1A MEN1 FREM2 MRTFB ALPK3 PRRC2B NPAT FAT4 PNN BICRA SIRT1 ADGRG6 ARID2 ATP2A2 | 2.19e-04 | 388 | 207 | 16 | MP:0006113 |
| MousePheno | pale yolk sac | 2.27e-04 | 110 | 207 | 8 | MP:0001722 | |
| MousePheno | bradykinesia | 2.29e-04 | 38 | 207 | 5 | MP:0005156 | |
| MousePheno | lethality throughout fetal growth and development | NCOA6 STAG1 UBE4B MIDEAS MEN1 MRTFB SEC24B FHIP1A FOXM1 ATMIN BICRA FLVCR1 SIRT1 DENND4C RAPGEF2 SPEN HTT | 2.62e-04 | 435 | 207 | 17 | MP:0006208 |
| MousePheno | thin myocardium | 2.62e-04 | 85 | 207 | 7 | MP:0002652 | |
| MousePheno | abnormal heart ventricle morphology | HDAC9 NCOA6 QRICH1 SSR1 ACVRL1 ARID1A WNK1 MEN1 MRTFB SEC24B ALPK3 CNOT3 PRRC2B NPAT FOXM1 PNN BICRA KLF15 RBM20 SIRT1 ADGRG6 ARID2 ATP2A2 HCFC1 RAI2 | 2.88e-04 | 793 | 207 | 25 | MP:0005294 |
| MousePheno | abnormal embryo development | NCOA6 KMT2B GATAD2A STAG1 TOMM20 SUPT20HL2 EXT2 SSR1 ACVRL1 ARID1A WNK1 TRIP12 LIN9 MEN1 FREM2 UBR5 FERMT2 NPAT POMT2 EP400 PNN BICRA COL27A1 EPB41L5 BCAR1 MED13L SIX1 TRIM33 IFT52 ARAP3 TENM4 MTOR PRORP RAPGEF2 CDH1 HTT | 4.69e-04 | 1370 | 207 | 36 | MP:0001672 |
| MousePheno | abnormal craniofacial morphology | STK36 BNC2 NCOA6 STAG1 GON4L QRICH1 ITGA4 ACVRL1 FREM1 MEN1 XYLT1 FREM2 MRTFB UBR5 SEC24B DLG1 PLAG1 GNAS SUCO PRRC2B ATMIN PNN COL27A1 FLVCR1 UBE3B GNPTAB MED13L SIX1 SIRT1 COL18A1 ZFHX4 YY1AP1 PEAK1 ATP2A2 HCFC1 HTT | 4.82e-04 | 1372 | 207 | 36 | MP:0000428 |
| MousePheno | craniofacial phenotype | STK36 BNC2 NCOA6 STAG1 GON4L QRICH1 ITGA4 ACVRL1 FREM1 MEN1 XYLT1 FREM2 MRTFB UBR5 SEC24B DLG1 PLAG1 GNAS SUCO PRRC2B ATMIN PNN COL27A1 FLVCR1 UBE3B GNPTAB MED13L SIX1 SIRT1 COL18A1 ZFHX4 YY1AP1 PEAK1 ATP2A2 HCFC1 HTT | 4.82e-04 | 1372 | 207 | 36 | MP:0005382 |
| MousePheno | abnormal embryonic tissue morphology | KMT2B GATAD2A SUPT20HL2 EXT2 ACVRL1 ARID1A LIN9 MEN1 FREM2 MRTFB UBR5 PRRC2C SEC24B DLG1 FERMT2 PRRC2B NPAT ATMIN FAT4 EP400 PNN WEE1 EPB41L5 SIX1 SIRT1 TRIM33 TENM4 MTOR RAPGEF2 CDH1 HTT | 4.86e-04 | 1116 | 207 | 31 | MP:0002085 |
| Domain | Znf_U1 | 3.42e-05 | 29 | 245 | 5 | IPR003604 | |
| Domain | ZnF_U1 | 3.42e-05 | 29 | 245 | 5 | SM00451 | |
| Domain | Med13_N | 1.71e-04 | 2 | 245 | 2 | PF11597 | |
| Domain | Mediator_Med13_N_met/fun | 1.71e-04 | 2 | 245 | 2 | IPR021643 | |
| Domain | Med13_C | 1.71e-04 | 2 | 245 | 2 | PF06333 | |
| Domain | Mediator_Med13 | 1.71e-04 | 2 | 245 | 2 | IPR009401 | |
| Domain | CH | 2.07e-04 | 65 | 245 | 6 | SM00033 | |
| Domain | Pentatricopeptide_repeat | 2.10e-04 | 23 | 245 | 4 | IPR002885 | |
| Domain | CH | 3.12e-04 | 70 | 245 | 6 | PF00307 | |
| Domain | - | 3.37e-04 | 71 | 245 | 6 | 1.10.418.10 | |
| Domain | CH | 3.92e-04 | 73 | 245 | 6 | PS50021 | |
| Domain | Znf_C2H2_matrin | 4.49e-04 | 12 | 245 | 3 | IPR000690 | |
| Domain | CH-domain | 4.53e-04 | 75 | 245 | 6 | IPR001715 | |
| Domain | BAT2_N | 5.10e-04 | 3 | 245 | 2 | PF07001 | |
| Domain | BAT2_N | 5.10e-04 | 3 | 245 | 2 | IPR009738 | |
| Domain | PRRC2 | 5.10e-04 | 3 | 245 | 2 | IPR033184 | |
| Pubmed | EPC2 ZHX3 NCOA6 ZNF536 HIVEP1 KMT2B GATAD2A MARS1 SEC24A LIN54 ZMYND8 GON4L ZNF318 ARID1A MIDEAS LIN9 KAT2B PRRC2C SYNE2 SEC24B NFRKB MLLT6 TAF4 CNOT3 ILVBL PRRC2B NPAT ZBTB33 EP400 PNN BICRA KLF15 TNRC6C ZHX2 RBM20 SIRT1 PCF11 TRIM33 ZFHX4 DCP1B ARID2 MDC1 STAU2 CCAR1 OTUD4 SMARCC2 SIX5 ZFHX3 YY1AP1 USP54 RPA1 SPEN ATP2A2 HCFC1 RAI2 | 1.64e-24 | 1429 | 253 | 55 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | EPC2 NCOA6 ZNF536 HIVEP1 KMT2B LIN54 ARID1A MIDEAS LIN9 KAT2B NFRKB TAF4 PRRC2B BAHCC1 EP400 BICRA ZHX2 SIRT1 TRIM33 ZFHX4 BAZ1A ARID2 MDC1 SMARCC2 ZFHX3 SPEN CDH1 | 1.00e-19 | 351 | 253 | 27 | 38297188 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | EPC2 ZHX3 HIVEP1 GATAD2A GON4L ARID1A SYNE2 NFRKB CIZ1 BAHCC1 EP400 BICRA PCLO ADNP2 KLF15 ZHX2 RBM20 TRIM33 ZFHX4 ARID2 SMARCC2 SIX5 YY1AP1 USP54 NUTM2F RPA1 RAI2 | 2.51e-18 | 398 | 253 | 27 | 35016035 |
| Pubmed | ZHX3 NCOA6 HIVEP1 LIN54 ZMYND8 MED14 ARID1A MIDEAS LIN9 NFRKB MED13 PRRC2B ZBTB33 EP400 PNN RANBP3 MED13L PCF11 TRIM33 MDC1 INTS4 SMARCC2 HCFC1 | 5.14e-18 | 268 | 253 | 23 | 33640491 | |
| Pubmed | TPR NCOA6 KMT2B MED14 ZNF318 ARID1A MIDEAS MRTFB PRRC2C SEC24B NFRKB CIZ1 DLG1 TAF4 PRRC2B ZBTB33 EP400 PNN RANBP3 HAUS5 LMO7 ARID2 MDC1 SEC23IP PEAK1 SPEN HCFC1 HTT | 9.01e-16 | 549 | 253 | 28 | 38280479 | |
| Pubmed | KMT2B MARS1 ZMYND8 MED14 GON4L ZNF318 SSR1 LIN9 NDUFS1 MYEF2 MEN1 MRTFB FBXO28 SEC24B NFRKB CIZ1 DLG1 UQCRFS1 TAF4 UTRN FHIP1A SDC1 CNOT3 MED13 ILVBL EP400 EPB41L5 ZHX2 PHC2 LRCH3 PCF11 TRIM33 COL18A1 BAZ1A ARID2 MDC1 STAU2 LRCH4 CCAR1 OTUD4 ZFHX3 CKAP2 SPEN ATP2A2 | 2.64e-15 | 1497 | 253 | 44 | 31527615 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR ZHX3 NCOA6 HIVEP1 KMT2B UBE4B ZMYND8 MED14 ZNF318 TRIP12 XPO6 NFRKB KIAA1958 DLG1 CNOT3 MED13 FOXM1 EP400 PNN WEE1 GTSE1 SIRT1 PHC2 PCF11 LMO7 MDC1 CCAR1 OTUD4 SMARCC2 YY1AP1 SPEN ATP2A2 | 2.64e-15 | 774 | 253 | 32 | 15302935 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR EPC2 ZNF536 GATAD2A STAG1 TRO LIN54 ZMYND8 QRICH1 TRIP12 LIN9 MYEF2 MEN1 XYLT1 PRDM10 UBR5 PRRC2C UQCRFS1 NOVA1 FOXM1 ZBTB33 EP400 SMARCAL1 GTSE1 SIX1 TRIM33 ATF6 ZFHX4 BAZ1A SMARCC2 SIX5 SPEN HCFC1 | 7.09e-15 | 857 | 253 | 33 | 25609649 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ZHX3 NCOA6 HIVEP1 GATAD2A LIN54 ZMYND8 ZNF318 ARID1A MIDEAS TRIP12 PRRC2C NFRKB CIZ1 MLLT6 TAF4 NPAT ZBTB33 CENPT EP400 PNN BICRA GTSE1 PCF11 TRIM33 BAZ1A ARID2 MDC1 STAU2 CCAR1 SMARCC2 SPEN ATP2A2 HCFC1 | 2.49e-14 | 954 | 253 | 34 | 36373674 |
| Pubmed | EPC2 ZHX3 NCOA6 HIVEP1 KMT2B GATAD2A MARS1 LIN54 ZMYND8 MED14 ZNF318 QRICH1 ARID1A MIDEAS LIN9 UBR5 PRRC2C NFRKB KIAA1958 MLLT6 TAF4 PRRC2B EP400 BICRA MED13L SIRT1 PCF11 TRIM33 ZC3H10 ARID2 CCAR1 SMARCC2 RPA1 SPEN ATP2A2 HCFC1 | 5.60e-14 | 1103 | 253 | 36 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 NCOA6 TBC1D9B KMT2B UBE4B MED14 IRS1 ARID1A WNK1 PIK3C2B XPO6 SNX8 MLLT6 PLA2G6 MED13 PRRC2B BAHCC1 ATMIN ZNF628 EP400 BICRA UBE3B GTSE1 LMTK2 TNRC6C MED13L PHC2 ARAP3 ZNF341 MTOR CSPG4 DIP2C SPEN HCFC1 HTT | 3.08e-13 | 1105 | 253 | 35 | 35748872 |
| Pubmed | ZHX3 ZNF536 UBE4B TRO GON4L KIAA0319 MAGI2 UBR5 PRRC2C FBXO28 PCDH19 ANKRD12 PRRC2B ATMIN EP400 TNRC6C MED13L ZHX2 TENM4 OTUD4 YY1AP1 SPEN | 3.93e-13 | 407 | 253 | 22 | 12693553 | |
| Pubmed | EPC2 ZNF536 IL16 GATAD2A ZMYND8 ZNF318 ARID1A ZKSCAN5 MYEF2 KAT2B UBR5 PCDH19 NFRKB CIZ1 TAF4 ILVBL PRRC2B BAHCC1 ZBTB33 EP400 WEE1 BICRA HAUS5 ADNP2 KIAA1549 OAS3 SIRT1 TRIM33 ZFHX4 ARID2 SMARCC2 ZFHX3 CEP295 USP54 RAPGEF2 | 4.08e-13 | 1116 | 253 | 35 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 HIVEP1 SEC24A SIK1 IRS1 RRM2 WNK1 TRIP12 FAM117A PIK3C2B PRRC2C SYNE2 SEC24B GNAS UTRN WEE1 RANBP3 GTSE1 LMTK2 EPB41L5 BCAR1 DENND4C DCP1B LMO7 MTOR USP54 CKAP2 PEAK1 RAPGEF2 OTOG | 1.65e-12 | 861 | 253 | 30 | 36931259 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZHX3 HIVEP1 KMT2B GATAD2A STAG1 LIN54 MIDEAS TRIP12 LIN9 MEN1 NFRKB CIZ1 MLLT6 TAF4 NPAT CENPT ADNP2 SIRT1 BAZ1A ARID2 MDC1 SMARCC2 RPA1 SPEN HCFC1 | 3.94e-12 | 608 | 253 | 25 | 36089195 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | STK36 NCOA6 TRO ZMYND8 WNK1 TRIP12 ZKSCAN5 MRTFB MLLT6 FHIP1A EP400 WEE1 BICRA RANBP3 GTSE1 BCAR1 USF3 ARID2 MDC1 STON2 SPEN | 9.34e-12 | 430 | 253 | 21 | 35044719 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ZHX3 NCOA6 STAG1 UBE4B ZMYND8 MED14 ARID1A MIDEAS MYEF2 MEN1 MRTFB EP400 RANBP3 SMARCAL1 MDC1 SMARCC2 YY1AP1 SPEN HCFC1 | 9.82e-12 | 341 | 253 | 19 | 32971831 |
| Pubmed | ZHX3 NCOA6 NFASC WNK1 LRCH1 MRTFB UBR5 XPO6 SYNE2 DAGLA GNPTAB TNRC6C MED13L TENM4 LMO7 DIP2C | 1.18e-11 | 225 | 253 | 16 | 12168954 | |
| Pubmed | EPC2 ZHX3 KMT2B GATAD2A LIN54 ZNF318 LIN9 NFRKB NPAT FOXM1 EP400 PNN GTSE1 TRIM33 YY1AP1 RPA1 SPEN HCFC1 | 7.70e-11 | 339 | 253 | 18 | 30415952 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 LIN54 ZNF318 ARID1A WNK1 MRTFB UBR5 PIK3C2B PRRC2C GNAS CNOT3 PRRC2B FOXM1 EP400 WEE1 BCAR1 RBM20 SIRT1 TRIM33 LMO7 ARID2 YY1AP1 SPEN | 8.00e-11 | 588 | 253 | 23 | 38580884 |
| Pubmed | STAG1 TRO LIN54 TOMM20 SIK1 ZNF318 TKTL1 DCC ARID1A TRIP12 NDUFS1 MEN1 FAM186A PRRC2C SYNE2 DLG1 TAF4 MED13 PRRC2B BAHCC1 PCDHGC5 PNN PCLO C2orf78 PCF11 LMO7 BAZ1A CSPG4 SEC23IP CCAR1 SMARCC2 CEP295 SPEN CDH1 ATP2A2 CFAP46 | 1.19e-10 | 1442 | 253 | 36 | 35575683 | |
| Pubmed | TPR ZNF536 HIVEP1 KMT2B LIN54 ZMYND8 ZNF318 LIN9 MRTFB UBR5 KIAA1958 UTRN NPAT ZBTB33 RBM20 DENND4C ZFHX4 SEC23IP ZFHX3 | 3.15e-10 | 418 | 253 | 19 | 34709266 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | EPC2 KMT2B LIN54 ZMYND8 ARID1A NFRKB ZBTB33 EP400 TRIM33 RPA1 SPEN HCFC1 | 3.25e-10 | 134 | 253 | 12 | 25452129 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | TPR NCOA6 GATAD2A ZMYND8 ZNF318 TRIP12 MRTFB ZBTB33 EP400 RANBP3 PCF11 MDC1 ZFHX3 RPA1 SPEN HCFC1 | 3.58e-10 | 283 | 253 | 16 | 30585729 |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 4.53e-10 | 59 | 253 | 9 | 28813667 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | CACUL1 GATAD2A LIN54 ZNF318 QRICH1 RRM2 SEC24B NFRKB TAF4 FOXM1 VPS37A ZBTB33 EP400 GTSE1 ZHX2 TRIM33 STAU2 RPA1 HCFC1 | 8.60e-10 | 444 | 253 | 19 | 34795231 |
| Pubmed | ZNF536 HIVEP1 TRIP12 LIN9 UBR5 NFRKB TAF4 PRRC2B EP400 WEE1 ADNP2 | 9.74e-10 | 116 | 253 | 11 | 30804394 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UBE4B MARS1 NFASC ARID1A MRTFB ANKIB1 DLG1 PLA2G6 ANKRD12 TAF4 GNAS UTRN DAGLA ATMIN VPS37A BICRA FLVCR1 TNRC6C BCAR1 ZHX2 LRCH3 ADGRG6 HIPK3 COL18A1 ATF6 USF3 EEPD1 CCAR1 DIP2C ZFHX3 LTBR CKAP2 PRORP RAPGEF2 HTT | 1.08e-09 | 1489 | 253 | 35 | 28611215 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPC2 NCOA6 KMT2B GATAD2A LIN54 ZMYND8 ZNF318 ARID1A MIDEAS TRIP12 LIN9 MEN1 FBXO28 NFRKB CIZ1 TAF4 ILVBL EP400 PNN DCLRE1B RFWD3 PHC2 LMO7 BAZ1A MDC1 CCAR1 INTS4 CKAP2 RPA1 SPEN ATP2A2 HCFC1 | 1.79e-09 | 1294 | 253 | 32 | 30804502 |
| Pubmed | EPC2 MED14 GON4L SSR1 WNK1 TRIP12 LIN9 MEN1 KAT2B CIZ1 UTRN MED13 FOXM1 CENPT EP400 HAUS5 MED13L DENND4C PHC2 CCAR1 CKAP2 SPEN | 2.65e-09 | 645 | 253 | 22 | 25281560 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | GATAD2A MED14 ARID1A MIDEAS TAF4 MED13 EP400 MED13L TRIM33 SMARCC2 RPA1 HCFC1 | 4.10e-09 | 167 | 253 | 12 | 20362541 |
| Pubmed | ZHX3 HIVEP1 KMT2B TRO ZMYND8 QRICH1 BPIFA1 WNK1 MLLT6 PRRC2B NOVA1 FAT4 ZHX2 PHC2 ZC3H10 SMARCC2 SIX5 YY1AP1 USP54 SPEN RAI2 | 4.97e-09 | 608 | 253 | 21 | 16713569 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | BNC2 KMT2B GATAD2A ARID1A MIDEAS MYEF2 MEN1 EP400 GTSE1 INTS4 HCFC1 | 1.12e-08 | 146 | 253 | 11 | 23892456 |
| Pubmed | ZHX3 NCOA6 ZNF536 HIVEP1 GATAD2A SSR1 ARID1A NDUFS1 MYEF2 SYNE2 PRRC2B FAT4 WEE1 SMARCAL1 IFI35 ARID2 SEC23IP OTUD4 SMARCC2 CEP295 SPEN | 1.15e-08 | 638 | 253 | 21 | 31182584 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | GATAD2A ZMYND8 GON4L ARID1A TAF4 EP400 ADNP2 MDC1 SMARCC2 CKAP2 HCFC1 | 1.48e-08 | 150 | 253 | 11 | 28242625 |
| Pubmed | SEC24A LIN54 LRRK2 ZNF318 TRIP12 UBR5 SEC24B DLG1 FERMT2 SDK1 PRRC2B FAT4 ZBTB33 EP400 FLVCR1 EPB41L5 PCF11 TRIM33 SEC23IP ZFHX3 PEAK1 RAPGEF2 SPEN | 1.61e-08 | 777 | 253 | 23 | 35844135 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | NCOA6 LIN54 ZMYND8 ZNF318 ARID1A MRTFB PRRC2C SYNE2 MDC1 HCFC1 | 2.54e-08 | 123 | 253 | 10 | 26912792 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MED14 ZNF318 RRM2 ARID1A TRIP12 MYEF2 UBR5 EP400 WEE1 LMTK2 LRCH3 PCF11 ARID2 MDC1 SMARCC2 USP54 CDH1 | 3.04e-08 | 440 | 253 | 17 | 34244565 |
| Pubmed | TPR MARS1 ZNF318 WNK1 TRIP12 MEN1 NFRKB FBXO7 DLG1 ANKRD12 FERMT2 SUCO UTRN NPAT LMTK2 TMEM39B CHST8 COL18A1 IFT52 ZNF341 BAZ1A OTUD4 CEP295 CKAP2 PEAK1 RPA1 CDH1 | 3.16e-08 | 1084 | 253 | 27 | 11544199 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SEC24A SIK1 WNK1 LRCH1 LIN9 MRTFB UBR5 PIK3C2B SEC24B GNAS FERMT2 CNOT3 VPS37A WEE1 GTSE1 HAUS5 TNRC6C DENND4C RFWD3 TRIM33 ARAP3 DCP1B MTOR SEC23IP OTUD4 RAPGEF2 | 5.17e-08 | 1038 | 253 | 26 | 26673895 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | TPR NCOA6 SEC24A QRICH1 RRM2 ARID1A MIDEAS MYEF2 PRRC2C PGLS PRRC2B RBM20 PCF11 TRIM33 DCP1B SEC23IP PRORP | 5.25e-08 | 457 | 253 | 17 | 32344865 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR GATAD2A UBE4B MARS1 RRM2 ARID1A MIDEAS TRIP12 NDUFS1 MYEF2 UBR5 SEC24B ANKIB1 FERMT2 UTRN SDC1 EP400 PNN MYO19 ADNP2 EPB41L5 OAS3 VTA1 ARAP3 BAZ1A MDC1 CCAR1 SMARCC2 RPA1 ATP2A2 | 6.75e-08 | 1353 | 253 | 30 | 29467282 |
| Pubmed | HDAC9 ZBTB38 STAG1 UBE4B ZMYND8 QRICH1 ARID1A TRIP12 ZKSCAN5 MAGI2 OSBPL1A FBXO7 DLG1 UTRN CNOT3 MED13 GNPTAB ADNP2 MED13L TRIM33 ATF6 LMO7 SEC23IP CCAR1 YY1AP1 USP54 CKAP2 RAPGEF2 ATP2A2 | 7.84e-08 | 1285 | 253 | 29 | 35914814 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ZHX3 MARS1 ZMYND8 ZNF318 WNK1 MRTFB PRRC2C SEC24B CIZ1 FERMT2 UTRN PRRC2B ZBTB33 EP400 PNN RANBP3 BAZ1A ARID2 STAU2 SEC23IP CKAP2 RPA1 HCFC1 | 1.09e-07 | 934 | 253 | 24 | 33916271 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | NCOA6 HIVEP1 KMT2B GATAD2A LIN54 SSR1 TRIP12 LIN9 MEN1 FBXO28 NFRKB FBXO7 ILVBL ADNP2 PHC2 ATP2A2 HCFC1 | 1.63e-07 | 495 | 253 | 17 | 27705803 |
| Pubmed | ZNF536 GATAD2A ZMYND8 ARID1A MYEF2 UBR5 FERMT2 CNOT3 EP400 PHC2 TRIM33 ZFHX4 SPEN | 1.80e-07 | 282 | 253 | 13 | 23667531 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | GATAD2A ZMYND8 GON4L ARID1A MIDEAS TRIP12 CIZ1 UTRN EP400 PHC2 BAZ1A ARID2 MDC1 SMARCC2 RPA1 | 2.42e-07 | 394 | 253 | 15 | 27248496 |
| Pubmed | 2.50e-07 | 87 | 253 | 8 | 12465718 | ||
| Pubmed | HDAC9 NCOA6 KMT2B GATAD2A ARID1A EP400 SMARCAL1 PHC2 ARID2 SMARCC2 | 2.55e-07 | 157 | 253 | 10 | 30186101 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | BHLHE41 ZHX3 ZBTB38 HIVEP1 GON4L MIDEAS PGR PLAG1 FOXM1 ZBTB33 CENPT ADNP2 KIAA1549 KLF15 POU6F1 SIX1 ZHX2 ATF6B ATF6 USF3 ZFHX4 SIX5 ZFHX3 | 2.61e-07 | 908 | 253 | 23 | 19274049 |
| Pubmed | STAG1 MED14 QRICH1 ARID1A MIDEAS UBR5 MED13 EP400 DCLRE1B MED13L ZHX2 TRIM33 MDC1 SMARCC2 RPA1 ATP2A2 | 2.62e-07 | 453 | 253 | 16 | 29656893 | |
| Pubmed | TPR ZHX3 MARS1 ZNF318 WNK1 PRRC2C PGLS PNN BICRA VTA1 ZHX2 PCF11 MDC1 SMARCC2 HCFC1 | 2.84e-07 | 399 | 253 | 15 | 35987950 | |
| Pubmed | TPR ZNF318 ARID1A TRIP12 NDUFS1 MYEF2 UBR5 PRRC2C SYNE2 UTRN PRRC2B PNN MTOR MDC1 CCAR1 SMARCC2 SPEN ATP2A2 HCFC1 | 3.87e-07 | 653 | 253 | 19 | 22586326 | |
| Pubmed | NCOA6 NFASC TOMM20 LRCH1 NACAD MYEF2 ANKIB1 DAGLA MED13 EP400 HAUS5 LMTK2 KIAA1549 TRIM33 LMO7 MDC1 IPO13 | 4.14e-07 | 529 | 253 | 17 | 14621295 | |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 4.44e-07 | 128 | 253 | 9 | 25332235 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | GATAD2A ZMYND8 MED14 SUPT20HL2 DCC WNK1 NDUFS1 MAGI2 FERMT2 UTRN COL6A3 RANBP3 STAU2 LRCH4 | 5.25e-07 | 363 | 253 | 14 | 14691545 |
| Pubmed | SEC24A ZNF318 ARID1A SEC24B UTRN PRRC2B PNN EPB41L5 KIAA1549 SEC23IP USP54 PEAK1 | 5.99e-07 | 263 | 253 | 12 | 34702444 | |
| Pubmed | TPR NFASC ZNF318 MYEF2 KIAA0319 MAGI2 UBR5 PRRC2C SYNE2 DLG1 TAF4 PRRC2B SGIP1 ATF6B MTOR SEC23IP STON2 CCAR1 OTUD4 SMARCC2 DGKI RAPGEF2 RPA1 | 7.21e-07 | 963 | 253 | 23 | 28671696 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | TPR ZMYND8 ARID1A MIDEAS MYEF2 TRIM33 ARID2 CCAR1 ZFHX3 RPA1 HCFC1 | 7.25e-07 | 220 | 253 | 11 | 35785414 |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 7.29e-07 | 69 | 253 | 7 | 28481362 | |
| Pubmed | HDAC9 STK36 TBC1D9B WNK1 ZKSCAN5 CNOT3 COL27A1 GNPTAB EPB41L5 PCF11 USF3 ARID2 EEPD1 DIP2C PEAK1 PRORP | 8.02e-07 | 493 | 253 | 16 | 15368895 | |
| Pubmed | 9.20e-07 | 103 | 253 | 8 | 32744500 | ||
| Pubmed | 9.91e-07 | 104 | 253 | 8 | 9205841 | ||
| Pubmed | TPR GATAD2A RRM2 WNK1 TRIP12 PNN GTSE1 BCAR1 SIRT1 DENND4C DCP1B LMO7 STAU2 OTUD4 SPEN HCFC1 | 1.04e-06 | 503 | 253 | 16 | 16964243 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 1.21e-06 | 186 | 253 | 10 | 33637726 | |
| Pubmed | 1.42e-06 | 147 | 253 | 9 | 29576527 | ||
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 20805893 | ||
| Pubmed | NCOA6 HIVEP1 KMT2B STAG1 ZMYND8 QRICH1 TRIP12 MRTFB UBR5 PLAG1 UTRN SDK1 HIPK3 DCP1B ZNF341 BAZ1A CSPG4 | 1.88e-06 | 591 | 253 | 17 | 15231748 | |
| Pubmed | IL16 MARS1 NFASC ARID1A NDUFS1 MYEF2 MAGI2 PRRC2C SORCS2 DLG1 UQCRFS1 FERMT2 UTRN DAGLA PRRC2B SGIP1 PCLO KIAA1549 LRCH3 TENM4 LMO7 STON2 OTUD4 SMARCC2 USP54 PEAK1 RAPGEF2 ATP2A2 | 2.23e-06 | 1431 | 253 | 28 | 37142655 | |
| Pubmed | ZHX3 NCOA6 GATAD2A STAG1 SEC24A ZMYND8 RRM2 ARID1A MIDEAS LRCH1 EP400 GTSE1 EPB41L5 BAZ1A ARID2 | 2.30e-06 | 472 | 253 | 15 | 38943005 | |
| Pubmed | 2.57e-06 | 83 | 253 | 7 | 28794006 | ||
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | SEC24A MYEF2 UBR5 SEC24B HAUS5 BCAR1 SPATA32 PHC2 DCP1B MTOR STON2 ZFHX3 USP54 HTT | 2.83e-06 | 419 | 253 | 14 | 33001583 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | TPR ZNF318 PRRC2C DLG1 FERMT2 ZBTB33 RANBP3 GTSE1 DENND4C LMO7 HCFC1 | 3.17e-06 | 256 | 253 | 11 | 33397691 |
| Pubmed | MARS1 TOMM20 EXT2 SSR1 RRM2 WNK1 TRIP12 NDUFS1 UBR5 PRRC2C SYNE2 SEC24B GNAS CNOT3 ILVBL PRRC2B VTA1 COL18A1 ATF6 BAZ1A MDC1 CCAR1 SMARCC2 RPA1 ATP2A2 HCFC1 | 3.42e-06 | 1297 | 253 | 26 | 33545068 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | GATAD2A RRM2 ARID1A MIDEAS MYEF2 FBXO28 CNOT3 ZBTB33 GTSE1 PHC2 BAZ1A SMARCC2 RPA1 | 3.74e-06 | 370 | 253 | 13 | 22922362 |
| Pubmed | SIRT1 plays an important role in implantation and decidualization during mouse early pregnancy. | 3.76e-06 | 5 | 253 | 3 | 35134122 | |
| Pubmed | IL16 FREM1 FREM2 COL6A3 ADAMTSL1 COL27A1 COL18A1 CSPG4 HCFC1 | 4.08e-06 | 167 | 253 | 9 | 22159717 | |
| Pubmed | 4.65e-06 | 16 | 253 | 4 | 16880404 | ||
| Pubmed | TPR EPC2 UBE4B MARS1 QRICH1 WNK1 NDUFS1 MEN1 PRDM10 UBR5 NFRKB PGLS TAF4 MED13 FOXM1 ATMIN WEE1 BICRA RANBP3 SMARCAL1 GNPTAB DCLRE1B MED13L SIRT1 ARID2 HTT | 5.14e-06 | 1327 | 253 | 26 | 32694731 | |
| Pubmed | ZHX3 ZNF536 HIVEP1 ZMYND8 ZNF318 QRICH1 ARID1A ZKSCAN5 PGR PLAG1 FOXM1 ZBTB33 POU6F1 SIX1 LMO7 BAZ1A SIX5 ZFHX3 | 5.30e-06 | 709 | 253 | 18 | 22988430 | |
| Pubmed | 5.31e-06 | 130 | 253 | 8 | 12421765 | ||
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 5.32e-06 | 35 | 253 | 5 | 26091241 | |
| Pubmed | TPR NCOA6 MARS1 MED14 IRS1 ARID1A TRIP12 NDUFS1 FASTK SEC24B DLG1 MLLT6 UQCRFS1 GNAS CNOT3 MED13 PNN MED13L LMO7 OTUD4 SMARCC2 RPA1 CDH1 ATP2A2 HCFC1 | 5.32e-06 | 1247 | 253 | 25 | 27684187 | |
| Pubmed | 5.55e-06 | 61 | 253 | 6 | 20305087 | ||
| Pubmed | ARID1A WNK1 LRCH1 UBR5 UTRN ILVBL KIAA1549 DENND4C LRCH3 LMO7 LRCH4 CEP295 USP54 RAPGEF2 | 5.78e-06 | 446 | 253 | 14 | 24255178 | |
| Pubmed | TPR ZHX3 GATAD2A ZMYND8 MED14 QRICH1 UBR5 TAF4 MED13 EP400 PNN SMARCAL1 MED13L SIRT1 PHC2 TRIM33 BAZ1A MDC1 CCAR1 SMARCC2 RPA1 HCFC1 | 5.91e-06 | 1014 | 253 | 22 | 32416067 | |
| Pubmed | 6.54e-06 | 177 | 253 | 9 | 26206133 | ||
| Pubmed | GON4L FREM2 PRRC2C ANKIB1 DLG1 ILVBL PRRC2B MYO19 UBE3B RBM20 RFWD3 TMEM177 ARAP3 LRCH4 CCAR1 YY1AP1 HCFC1 | 6.61e-06 | 650 | 253 | 17 | 38777146 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR GATAD2A MARS1 ZNF318 TRIP12 MYEF2 UBR5 SYNE2 CIZ1 GNAS UTRN EP400 PNN GTSE1 HAUS5 LMO7 BAZ1A MDC1 SMARCC2 RPA1 SPEN ATP2A2 | 6.89e-06 | 1024 | 253 | 22 | 24711643 |
| Pubmed | GATAD2A MARS1 MIDEAS NDUFS1 MYEF2 UBR5 PRRC2C TAF4 GNAS ILVBL PRRC2B PNN EPB41L5 STAU2 USP54 RPA1 ATP2A2 | 7.30e-06 | 655 | 253 | 17 | 35819319 | |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | NCOA6 GATAD2A MED14 ARID1A MYEF2 PRDM10 UQCRFS1 ATMIN IQCA1 CCAR1 SPEN | 8.20e-06 | 283 | 253 | 11 | 18854154 |
| Pubmed | ZHX3 BNC2 HIVEP1 ZMYND8 ZNF318 ARID1A KAT2B CIZ1 PLAG1 MLLT6 FOXM1 ZBTB33 KLF15 ATF6B ZC3H10 BAZ1A ARID2 CCAR1 ZFHX3 | 8.57e-06 | 808 | 253 | 19 | 20412781 | |
| Pubmed | 8.93e-06 | 100 | 253 | 7 | 10048485 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 8.95e-06 | 184 | 253 | 9 | 32908313 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | MAN2C1 CCNDBP1 SSR1 DCC ARID1A UBR5 USH2A ILVBL PNN WEE1 GTSE1 SIRT1 MTOR MDC1 CCAR1 RPA1 ATP2A2 | 9.78e-06 | 670 | 253 | 17 | 22990118 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ZHX3 GATAD2A ZMYND8 MED14 ARID1A TRIP12 NFRKB TAF4 CENPT PNN BICRA PHC2 BAZ1A MDC1 SMARCC2 | 9.88e-06 | 533 | 253 | 15 | 30554943 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | BNC2 GATAD2A STAG1 QRICH1 ARID1A DLG1 MED13 RANBP3 TMEM39B MED13L HIPK3 TENM4 ARID2 ZFHX3 PEAK1 | 1.06e-05 | 536 | 253 | 15 | 15840001 |
| Pubmed | BNC2 GATAD2A STAG1 QRICH1 ARID1A DLG1 MED13 RANBP3 TMEM39B MED13L HIPK3 TENM4 ARID2 ZFHX3 PEAK1 | 1.10e-05 | 538 | 253 | 15 | 10512203 | |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 1.35e-05 | 71 | 253 | 6 | 28319113 | |
| Pubmed | ITGA4 LRCH1 PIK3C2B PCDH19 DLG1 FERMT2 UTRN FLVCR1 EPB41L5 LRCH3 EEPD1 SEC23IP PEAK1 | 1.48e-05 | 421 | 253 | 13 | 36976175 | |
| Interaction | NUP43 interactions | NCOA6 HIVEP1 KMT2B GATAD2A LIN54 ZMYND8 GON4L ZNF318 RRM2 ARID1A MIDEAS TRIP12 MRTFB UBR5 PRRC2C SYNE2 NFRKB CIZ1 PGLS MLLT6 TAF4 NPAT CENPT EP400 PNN ZHX2 BAZ1A ARID2 MDC1 ZFHX3 RAPGEF2 SPEN HCFC1 | 1.62e-12 | 625 | 247 | 33 | int:NUP43 |
| Interaction | NFYC interactions | HIVEP1 LIN54 GON4L LIN9 KAT2B NFRKB TAF4 EP400 BICRA ADNP2 KLF15 POU6F1 ATF6B ATF6 USF3 ARID2 YY1AP1 NUTM2F | 6.89e-12 | 177 | 247 | 18 | int:NFYC |
| Interaction | SNRNP40 interactions | HIVEP1 KMT2B GATAD2A LRRK2 GON4L ZNF318 QRICH1 ARID1A MIDEAS MEN1 PRDM10 UBR5 NFRKB CIZ1 MLLT6 TAF4 NPAT CENPT EP400 PNN SMARCAL1 ADNP2 ZHX2 RBM20 ARID2 MDC1 CCAR1 INTS4 SMARCC2 ZFHX3 RPA1 SPEN | 1.34e-11 | 637 | 247 | 32 | int:SNRNP40 |
| Interaction | SP7 interactions | EPC2 NCOA6 ZNF536 HIVEP1 KMT2B LIN54 ZNF318 ARID1A MIDEAS KAT2B PRRC2B EP400 PNN BICRA RBM20 PCF11 TRIM33 ZFHX4 ARID2 CCAR1 SMARCC2 ATP2A2 | 2.78e-11 | 304 | 247 | 22 | int:SP7 |
| Interaction | HNF4A interactions | EPC2 NCOA6 HIVEP1 KMT2B LIN54 MED14 EXT2 ARID1A MIDEAS LIN9 KAT2B NFRKB TAF4 EP400 BICRA ZHX2 SIRT1 TRIM33 ARID2 SMARCC2 SPEN | 2.92e-11 | 275 | 247 | 21 | int:HNF4A |
| Interaction | EGR2 interactions | NCOA6 ZNF536 HIVEP1 ARID1A MIDEAS KAT2B NFRKB PRRC2B BAHCC1 EP400 BICRA TRIM33 ZFHX4 ARID2 ZFHX3 CDH1 HCFC1 | 3.86e-11 | 171 | 247 | 17 | int:EGR2 |
| Interaction | CRX interactions | EPC2 ZNF536 QRICH1 ARID1A MIDEAS LIN9 NFRKB MLLT6 PRRC2B BAHCC1 EP400 BICRA ZHX2 TRIM33 ZC3H10 ZFHX4 ARID2 IPO13 ZFHX3 SPEN | 5.07e-11 | 254 | 247 | 20 | int:CRX |
| Interaction | AR interactions | TPR ZHX3 NCOA6 HIVEP1 CACUL1 LIN54 ZMYND8 MED14 ZNF318 DCC RRM2 ARID1A MIDEAS LIN9 MYEF2 KAT2B UBR5 NFRKB GNAS MED13 PRRC2B ZBTB33 EP400 PNN RANBP3 MED13L SIRT1 PCF11 HIPK3 TRIM33 ARID2 MDC1 CCAR1 INTS4 SMARCC2 ZFHX3 USP54 RPA1 HCFC1 | 1.08e-10 | 992 | 247 | 39 | int:AR |
| Interaction | HNF1B interactions | ZNF536 HIVEP1 LIN54 ARID1A BPIFA1 MIDEAS LIN9 KAT2B NFRKB MLLT6 PRRC2B EP400 BICRA ZFHX4 ARID2 ZFHX3 USP54 | 2.05e-10 | 190 | 247 | 17 | int:HNF1B |
| Interaction | HDAC1 interactions | BHLHE41 HDAC9 TPR ZHX3 ZNF536 HIVEP1 KMT2B GATAD2A STAG1 ZMYND8 GON4L ZNF318 SSR1 ARID1A MIDEAS LIN9 MEN1 MRTFB UBR5 SYNE2 UTRN BAHCC1 NPAT ZBTB33 EP400 VTA1 ZHX2 RBM20 SIRT1 DENND4C LRCH3 ZFHX4 LMO7 BAZ1A SEC23IP SMARCC2 ZFHX3 RPA1 SPEN CDH1 HCFC1 | 2.12e-10 | 1108 | 247 | 41 | int:HDAC1 |
| Interaction | TERF2IP interactions | ZHX3 NCOA6 ZNF536 HIVEP1 KMT2B GATAD2A LIN54 ZMYND8 ZNF318 ARID1A TRIP12 LIN9 NFRKB CIZ1 PGLS TAF4 NPAT EP400 DCLRE1B PCF11 TRIM33 ZC3H10 MDC1 CCAR1 SMARCC2 RPA1 SPEN HCFC1 | 2.26e-10 | 552 | 247 | 28 | int:TERF2IP |
| Interaction | TNRC6A interactions | NCOA6 KMT2B GATAD2A MED14 TOMM20 ARID1A WNK1 UBR5 SEC24B CNOT3 MED13 PRRC2B GTSE1 TNRC6C PCF11 DCP1B MDC1 OTUD4 USP54 RPA1 | 2.89e-10 | 280 | 247 | 20 | int:TNRC6A |
| Interaction | FEV interactions | NCOA6 HIVEP1 KMT2B LIN54 ARID1A MIDEAS NFRKB TAF4 PRRC2B EP400 BICRA ZHX2 ZFHX4 ARID2 SIX5 ZFHX3 YY1AP1 | 5.76e-10 | 203 | 247 | 17 | int:FEV |
| Interaction | ASF1A interactions | NCOA6 ZNF536 HIVEP1 KMT2B GATAD2A LIN54 ARID1A NFRKB MLLT6 NPAT EP400 BICRA TRIM33 ARID2 MDC1 SMARCC2 SPEN HCFC1 | 1.91e-09 | 249 | 247 | 18 | int:ASF1A |
| Interaction | NFIX interactions | ZNF536 HIVEP1 KMT2B LIN54 QRICH1 ARID1A MIDEAS NFRKB TAF4 EP400 BICRA ZHX2 ZFHX4 ARID2 SMARCC2 ZFHX3 SPEN | 3.20e-09 | 227 | 247 | 17 | int:NFIX |
| Interaction | PAX6 interactions | NCOA6 ZNF536 HIVEP1 LIN54 QRICH1 ARID1A MIDEAS LIN9 NFRKB DLG1 MLLT6 PRRC2B EP400 BICRA RANBP3 ZHX2 ZFHX4 ARID2 IPO13 SMARCC2 ZFHX3 | 5.38e-09 | 366 | 247 | 21 | int:PAX6 |
| Interaction | SMC5 interactions | TPR ZHX3 NCOA6 HIVEP1 GATAD2A LIN54 ZMYND8 ZNF318 ARID1A MIDEAS TRIP12 PRRC2C NFRKB CIZ1 MLLT6 TAF4 NPAT ZBTB33 CENPT EP400 PNN BICRA GTSE1 BCAR1 PCF11 TRIM33 BAZ1A ARID2 MDC1 STAU2 CCAR1 SMARCC2 RPA1 SPEN ATP2A2 HCFC1 | 6.38e-09 | 1000 | 247 | 36 | int:SMC5 |
| Interaction | CEBPA interactions | BHLHE41 EPC2 ZHX3 NCOA6 HIVEP1 KMT2B GATAD2A STAG1 MARS1 LIN54 ZMYND8 MED14 ZNF318 QRICH1 ARID1A MIDEAS LIN9 UBR5 PRRC2C NFRKB KIAA1958 MLLT6 TAF4 PRRC2B EP400 PNN BICRA MED13L SIRT1 PCF11 TRIM33 ZC3H10 BAZ1A ARID2 CCAR1 SMARCC2 YY1AP1 RPA1 SPEN ATP2A2 HCFC1 | 6.47e-09 | 1245 | 247 | 41 | int:CEBPA |
| Interaction | TLE3 interactions | HIVEP1 SEC24A ZNF318 QRICH1 ARID1A MIDEAS MEN1 UBR5 NFRKB FBXO7 MLLT6 TAF4 SIX1 RBM20 ARID2 CCAR1 OTUD4 INTS4 SMARCC2 ZFHX3 SPEN | 8.63e-09 | 376 | 247 | 21 | int:TLE3 |
| Interaction | ATXN1 interactions | TPR ZHX3 TBC1D9B HIVEP1 KMT2B GATAD2A MARS1 TOMM20 QRICH1 ARID1A WNK1 MYEF2 PRRC2C SYNE2 PGLS UQCRFS1 GNAS CNOT3 ILVBL PRRC2B FAT4 PNN RANBP3 SCAMP2 ZHX2 ZC3H10 CCAR1 SMARCC2 SIX5 YY1AP1 USP54 RPA1 SPEN ATP2A2 HCFC1 RAI2 | 1.71e-08 | 1039 | 247 | 36 | int:ATXN1 |
| Interaction | FHL2 interactions | EPC2 IL16 ZSCAN9 QRICH1 WNK1 MRTFB PRRC2C CNOT3 BAHCC1 ADAMTSL1 EP400 EPB41L5 MAP10 IFI35 SIRT1 CCAR1 SIX5 YY1AP1 SPEN RAI2 HTT | 2.12e-08 | 396 | 247 | 21 | int:FHL2 |
| Interaction | KLF3 interactions | EPC2 ZHX3 ZNF536 HIVEP1 KMT2B GATAD2A LIN54 ARID1A MIDEAS KAT2B NFRKB TAF4 EP400 ZHX2 ARID2 ZFHX3 | 2.36e-08 | 228 | 247 | 16 | int:KLF3 |
| Interaction | YWHAG interactions | NCOA6 HIVEP1 SEC24A LRRK2 SIK1 IRS1 ITGA4 RRM2 WNK1 TRIP12 FAM117A PIK3C2B PRRC2C SYNE2 SEC24B GNAS SUCO UTRN ZBTB33 PNN WEE1 RANBP3 GTSE1 LMTK2 EPB41L5 BCAR1 DENND4C LRCH3 DCP1B LMO7 BAZ1A MTOR USP54 CKAP2 PEAK1 RAPGEF2 RPA1 HTT OTOG | 6.50e-08 | 1248 | 247 | 39 | int:YWHAG |
| Interaction | TOP3B interactions | STK36 NCOA6 TBC1D9B KMT2B UBE4B SEC24A MED14 IRS1 RRM2 ARID1A WNK1 PIK3C2B FASTK XPO6 SEC24B SNX8 MLLT6 PLA2G6 GNAS MED13 PRRC2B BAHCC1 ATMIN ZNF628 EP400 BICRA UBE3B GTSE1 LMTK2 TNRC6C MED13L PHC2 ARAP3 ZNF341 MTOR CSPG4 MDC1 DIP2C OTUD4 RPA1 SPEN HCFC1 HTT | 8.11e-08 | 1470 | 247 | 43 | int:TOP3B |
| Interaction | H2BC21 interactions | EPC2 KMT2B GATAD2A MARS1 ZMYND8 SIK1 ARID1A MIDEAS TRIP12 MEN1 KAT2B MRTFB FBXO28 BAHCC1 EP400 PNN SMARCAL1 PCLO PHC2 USF3 BAZ1A ARID2 MDC1 SMARCC2 CKAP2 HCFC1 CFAP46 | 1.36e-07 | 696 | 247 | 27 | int:H2BC21 |
| Interaction | H3-3A interactions | HDAC9 ZHX3 HIVEP1 KMT2B GATAD2A STAG1 LIN54 LRRK2 ITGA4 MIDEAS TRIP12 LIN9 MEN1 KAT2B NFRKB MLLT6 TAF4 NPAT CENPT ADNP2 SIRT1 BAZ1A ARID2 MDC1 SMARCC2 RPA1 SPEN HCFC1 | 1.68e-07 | 749 | 247 | 28 | int:H3-3A |
| Interaction | ELF4 interactions | EPC2 KMT2B LIN54 KAT2B NFRKB FBXO7 TAF4 EP400 ZHX2 TRIM33 ARID2 | 1.74e-07 | 115 | 247 | 11 | int:ELF4 |
| Interaction | H2BC8 interactions | EPC2 ZHX3 KMT2B GATAD2A STAG1 LIN54 ZMYND8 GON4L ITGA4 MIDEAS TRIP12 LIN9 MEN1 NFRKB CIZ1 FOXM1 CENPT EP400 PHC2 BAZ1A MDC1 SMARCC2 CKAP2 SPEN | 1.94e-07 | 576 | 247 | 24 | int:H2BC8 |
| Interaction | YWHAH interactions | NCOA6 HIVEP1 SEC24A LRRK2 SIK1 IRS1 RRM2 WNK1 TRIP12 FAM117A PIK3C2B PRRC2C SYNE2 SEC24B FERMT2 SUCO UTRN PNN WEE1 RANBP3 GTSE1 LMTK2 EPB41L5 KLF15 BCAR1 DENND4C DCP1B LMO7 MTOR USP54 PEAK1 RAPGEF2 RPA1 HTT OTOG | 2.29e-07 | 1102 | 247 | 35 | int:YWHAH |
| Interaction | SMAD3 interactions | NCOA6 HIVEP1 KMT2B IRS1 ARID1A LRCH1 MEN1 MAGI2 KAT2B XPO6 PLAG1 FOXM1 WEE1 EPB41L5 PHC2 TRIM33 SMARCC2 ZFHX3 RPA1 CDH1 | 7.09e-07 | 447 | 247 | 20 | int:SMAD3 |
| Interaction | YY1 interactions | ZHX3 HIVEP1 KMT2B LIN54 ZMYND8 GON4L TRIP12 LIN9 MEN1 KAT2B NFRKB TAF4 EP400 ZHX2 ATF6 MTOR ARID2 MDC1 RPA1 HCFC1 | 9.03e-07 | 454 | 247 | 20 | int:YY1 |
| Interaction | WWTR1 interactions | HDAC9 NCOA6 IL16 ZNF318 ARID1A PRRC2C SEC24B DLG1 PRRC2B ZBTB33 EP400 PNN HAUS5 LMO7 ARID2 SEC23IP PEAK1 HCFC1 HTT | 1.24e-06 | 422 | 247 | 19 | int:WWTR1 |
| Interaction | PHF21A interactions | TPR ZNF536 HIVEP1 KMT2B ZMYND8 ZNF318 MRTFB UBR5 UTRN NPAT ZBTB33 RBM20 DENND4C ZFHX4 SEC23IP ZFHX3 RPA1 | 1.25e-06 | 343 | 247 | 17 | int:PHF21A |
| Interaction | PML interactions | CACUL1 KMT2B GATAD2A MARS1 LIN54 TOMM20 ZNF318 QRICH1 RRM2 NDUFS1 UBR5 SYNE2 SEC24B NFRKB TAF4 FOXM1 VPS37A ZBTB33 EP400 GTSE1 OAS3 ZHX2 SIRT1 TRIM33 LMO7 MTOR MDC1 STAU2 HCFC1 HTT | 1.42e-06 | 933 | 247 | 30 | int:PML |
| Interaction | KLF8 interactions | EPC2 HIVEP1 KMT2B LIN54 KAT2B PRRC2C NFRKB TAF4 PRRC2B EP400 BICRA ZHX2 TRIM33 ARID2 SPEN ATP2A2 | 3.30e-06 | 329 | 247 | 16 | int:KLF8 |
| Interaction | H3C3 interactions | ZHX3 HIVEP1 KMT2B GATAD2A STAG1 LIN54 ITGA4 MIDEAS TRIP12 NFRKB CIZ1 MLLT6 NPAT ADNP2 BAZ1A ARID2 MDC1 SMARCC2 RPA1 SPEN | 3.38e-06 | 495 | 247 | 20 | int:H3C3 |
| Interaction | GATA3 interactions | ZNF536 HIVEP1 ARID1A MIDEAS MEN1 MLLT6 PRRC2B WEE1 RBM20 PCF11 ZFHX4 CCAR1 | 3.53e-06 | 187 | 247 | 12 | int:GATA3 |
| Interaction | MEN1 interactions | ZHX3 NCOA6 KMT2B GATAD2A STAG1 UBE4B MARS1 ZMYND8 MED14 ARID1A MIDEAS TRIP12 MYEF2 MEN1 MRTFB UBR5 EP400 PNN RANBP3 SMARCAL1 PCF11 LMO7 BAZ1A ARID2 MDC1 SMARCC2 YY1AP1 RPA1 SPEN ATP2A2 HCFC1 | 3.60e-06 | 1029 | 247 | 31 | int:MEN1 |
| Interaction | PICALM interactions | ITGA4 WNK1 FERMT2 ILVBL PRRC2B MYO19 GTSE1 ATF6B SIRT1 ZC3H10 STON2 RPA1 CDH1 HTT | 4.89e-06 | 263 | 247 | 14 | int:PICALM |
| Interaction | FLOT1 interactions | MYEF2 FBXO7 DLG1 FERMT2 UTRN ILVBL EP400 MYO19 PCLO LMTK2 EPB41L5 KIAA1549 BCAR1 OTUD4 USP54 PEAK1 RPA1 CDH1 HTT | 6.89e-06 | 475 | 247 | 19 | int:FLOT1 |
| Interaction | SOX7 interactions | 7.42e-06 | 82 | 247 | 8 | int:SOX7 | |
| Interaction | SRF interactions | 8.52e-06 | 139 | 247 | 10 | int:SRF | |
| Interaction | BAG2 interactions | NCOA6 ZBTB38 LRRK2 ZNF318 QRICH1 RRM2 WNK1 MEN1 MRTFB PRRC2C NFRKB CIZ1 FBXO7 CNOT3 HAUS5 TRIM33 MDC1 OTUD4 CKAP2 RPA1 SPEN HTT | 9.12e-06 | 622 | 247 | 22 | int:BAG2 |
| Interaction | SMG7 interactions | NCOA6 HIVEP1 TOMM20 ZNF318 ARID1A MLLT6 CNOT3 PRRC2B TNRC6C RBM20 SIRT1 PCF11 CCAR1 OTUD4 RPA1 | 1.00e-05 | 319 | 247 | 15 | int:SMG7 |
| Interaction | CDC16 interactions | ZNF318 RRM2 MEN1 TAF4 WEE1 GTSE1 HAUS5 SIRT1 TRIM33 MDC1 YY1AP1 CEP295 USP54 | 1.16e-05 | 246 | 247 | 13 | int:CDC16 |
| Interaction | RCOR1 interactions | TPR ZNF536 HIVEP1 KMT2B GATAD2A ZMYND8 ZNF318 MRTFB UBR5 UTRN NPAT ZBTB33 VTA1 RBM20 DENND4C ZFHX4 SMARCC2 ZFHX3 SPEN | 1.20e-05 | 494 | 247 | 19 | int:RCOR1 |
| Interaction | FBXO38 interactions | 1.24e-05 | 145 | 247 | 10 | int:FBXO38 | |
| Interaction | TBXT interactions | 1.32e-05 | 116 | 247 | 9 | int:TBXT | |
| Interaction | KDM1A interactions | TPR IL16 HIVEP1 KMT2B LIN54 ZMYND8 ZNF318 LIN9 NDUFS1 MRTFB UBR5 KIAA1958 UTRN CNOT3 NPAT VPS37A ZBTB33 EP400 IFI35 RBM20 DENND4C PHC2 ZFHX4 SEC23IP SMARCC2 ZFHX3 RPA1 HTT | 1.39e-05 | 941 | 247 | 28 | int:KDM1A |
| Interaction | MAD2L1 interactions | TPR HIVEP1 LIN54 ZNF318 UBR5 PNN ADNP2 TRIM33 CSF2RB MDC1 CKAP2 PEAK1 RPA1 | 1.49e-05 | 252 | 247 | 13 | int:MAD2L1 |
| Interaction | SFN interactions | HDAC9 NCOA6 LRRK2 IRS1 WNK1 TRIP12 PIK3C2B PRRC2C ZBTB33 WEE1 RANBP3 LMTK2 EPB41L5 BCAR1 DENND4C LMO7 MTOR CCAR1 USP54 PEAK1 RPA1 CDH1 HTT | 1.54e-05 | 692 | 247 | 23 | int:SFN |
| Interaction | PRPS2 interactions | EPC2 GATAD2A LIN54 LIN9 NFRKB FOXM1 ZBTB33 HAUS5 ADNP2 BCAR1 YY1AP1 PEAK1 RPA1 | 1.56e-05 | 253 | 247 | 13 | int:PRPS2 |
| Interaction | H2AC4 interactions | ZMYND8 GON4L ITGA4 ARID1A MIDEAS TRIP12 KAT2B PRDM10 UBR5 CIZ1 TAF4 EP400 BCAR1 PHC2 USF3 BAZ1A ARID2 RPA1 HCFC1 | 1.67e-05 | 506 | 247 | 19 | int:H2AC4 |
| Interaction | LHX2 interactions | ZNF536 HIVEP1 LIN54 ARID1A LIN9 EP400 ZHX2 ZFHX4 ARID2 SMARCC2 ZFHX3 | 1.67e-05 | 183 | 247 | 11 | int:LHX2 |
| Interaction | RBBP7 interactions | ZBTB38 HIVEP1 GATAD2A STAG1 ZMYND8 ARID1A LIN9 MEN1 BAHCC1 NPAT EP400 ZHX2 SIRT1 ARAP3 BAZ1A SMARCC2 RPA1 SPEN HCFC1 | 1.72e-05 | 507 | 247 | 19 | int:RBBP7 |
| Interaction | LHX3 interactions | HIVEP1 QRICH1 DCC ARID1A MIDEAS SYNE2 NFRKB ZHX2 ZFHX4 ARID2 INTS4 | 1.85e-05 | 185 | 247 | 11 | int:LHX3 |
| Interaction | ESRRB interactions | GATAD2A ZMYND8 MED14 SSR1 ARID1A NFRKB TAF4 MED13 EP400 MED13L SMARCC2 ATP2A2 HCFC1 | 2.25e-05 | 262 | 247 | 13 | int:ESRRB |
| Interaction | HDAC2 interactions | HDAC9 ZHX3 GATAD2A STAG1 MARS1 ZMYND8 IRS1 ZNF318 ARID1A WNK1 MIDEAS LIN9 MEN1 KAT2B PRRC2C EP400 ZHX2 SIRT1 DENND4C PHC2 BAZ1A SMARCC2 RPA1 SPEN CDH1 HCFC1 | 2.42e-05 | 865 | 247 | 26 | int:HDAC2 |
| Interaction | ELF1 interactions | 2.56e-05 | 126 | 247 | 9 | int:ELF1 | |
| Interaction | GSK3B interactions | BHLHE41 MARS1 LRRK2 IRS1 SSR1 ACVRL1 TRIP12 NDUFS1 UBR5 XPO6 PRRC2C FBXO7 FERMT2 UTRN FOXM1 HAUS5 VTA1 BCAR1 DENND4C DCP1B MTOR STAU2 PEAK1 RPA1 IGSF21 CDH1 | 2.56e-05 | 868 | 247 | 26 | int:GSK3B |
| Interaction | SOX9 interactions | 2.57e-05 | 97 | 247 | 8 | int:SOX9 | |
| Interaction | PPARG interactions | HDAC9 NCOA6 ZNF536 HIVEP1 MED14 MEN1 KAT2B UBR5 MLLT6 ATMIN BICRA RANBP3 SIRT1 ARID2 | 2.79e-05 | 307 | 247 | 14 | int:PPARG |
| Interaction | TFCP2L1 interactions | 2.98e-05 | 99 | 247 | 8 | int:TFCP2L1 | |
| Interaction | YWHAZ interactions | HDAC9 HIVEP1 SEC24A LRRK2 SIK1 IRS1 ITGA4 ARID1A WNK1 LRCH1 TRIP12 PIK3C2B SYNE2 FERMT2 SUCO ZBTB33 WEE1 BCAR1 ZHX2 DENND4C CSF2RB DCP1B LMO7 MTOR MDC1 OTUD4 USP54 PEAK1 RAPGEF2 RPA1 CDH1 ATP2A2 HTT OTOG | 3.20e-05 | 1319 | 247 | 34 | int:YWHAZ |
| Interaction | YAP1 interactions | TPR NCOA6 KMT2B MARS1 MED14 ZNF318 ARID1A MIDEAS MEN1 MRTFB PRRC2C NFRKB CIZ1 DLG1 TAF4 GNAS ZBTB33 PNN RANBP3 KLF15 SIRT1 COL18A1 ARID2 MDC1 SMARCC2 RAPGEF2 RPA1 SPEN CDH1 HCFC1 | 3.21e-05 | 1095 | 247 | 30 | int:YAP1 |
| Interaction | MED15 interactions | 3.48e-05 | 131 | 247 | 9 | int:MED15 | |
| Interaction | GATA2 interactions | NCOA6 ZNF536 HIVEP1 MARS1 ARID1A MIDEAS PRRC2B ZFHX4 ARID2 SMARCC2 ZFHX3 | 3.64e-05 | 199 | 247 | 11 | int:GATA2 |
| Interaction | PHF20L1 interactions | 3.73e-05 | 75 | 247 | 7 | int:PHF20L1 | |
| Interaction | STAT3 interactions | HIVEP1 SIK1 NACAD PGR KAT2B SYNE2 FOXM1 KLF15 POU6F1 BCAR1 SIRT1 CSF2RB MTOR ZFHX3 RPA1 CDH1 ATP2A2 | 3.89e-05 | 446 | 247 | 17 | int:STAT3 |
| Interaction | MYB interactions | 3.92e-05 | 133 | 247 | 9 | int:MYB | |
| Interaction | SS18L2 interactions | 4.06e-05 | 76 | 247 | 7 | int:SS18L2 | |
| Interaction | NFYA interactions | 4.56e-05 | 105 | 247 | 8 | int:NFYA | |
| Interaction | TTC9C interactions | 4.67e-05 | 136 | 247 | 9 | int:TTC9C | |
| Interaction | SUPT5H interactions | HIVEP1 MED14 SIK1 ARID1A UBR5 SYNE2 NFRKB NPAT EP400 PNN BICRA RANBP3 PCF11 INTS4 RPA1 SPEN | 4.71e-05 | 408 | 247 | 16 | int:SUPT5H |
| Interaction | H3C1 interactions | TPR KMT2B GATAD2A STAG1 ZMYND8 LRRK2 MED14 ITGA4 MIDEAS TRIP12 MEN1 KAT2B PRRC2C TAF4 FAT4 CENPT SIRT1 TRIM33 BAZ1A ARID2 MDC1 SMARCC2 ZFHX3 RPA1 SPEN CDH1 | 4.79e-05 | 901 | 247 | 26 | int:H3C1 |
| Interaction | CBX3 interactions | HDAC9 ZHX3 KMT2B LIN54 ZMYND8 LRRK2 TRIP12 MEN1 PRDM10 NFRKB TAF4 PRRC2B CENPT EP400 ADNP2 SIRT1 TRIM33 ARID2 MDC1 RPA1 SPEN | 5.03e-05 | 646 | 247 | 21 | int:CBX3 |
| Interaction | PRRC1 interactions | 5.59e-05 | 55 | 247 | 6 | int:PRRC1 | |
| Interaction | DUXB interactions | 5.89e-05 | 18 | 247 | 4 | int:DUXB | |
| Interaction | FOXJ2 interactions | 6.13e-05 | 81 | 247 | 7 | int:FOXJ2 | |
| Interaction | KLF15 interactions | EPC2 HIVEP1 LIN54 LIN9 KAT2B PRRC2C NFRKB TAF4 PRRC2B EP400 KLF15 ARID2 RAI2 | 6.42e-05 | 290 | 247 | 13 | int:KLF15 |
| Interaction | ARL16 interactions | 7.17e-05 | 83 | 247 | 7 | int:ARL16 | |
| Interaction | LHX6 interactions | 7.58e-05 | 58 | 247 | 6 | int:LHX6 | |
| Interaction | KLF16 interactions | ZBTB38 HIVEP1 KMT2B LIN54 GON4L PRRC2C NFRKB TAF4 PRRC2B NPAT ZBTB33 EP400 ZHX2 ARID2 RPA1 ATP2A2 | 7.61e-05 | 425 | 247 | 16 | int:KLF16 |
| Interaction | ELF5 interactions | 8.55e-05 | 147 | 247 | 9 | int:ELF5 | |
| Interaction | NUP50 interactions | CACUL1 ZNF318 ARID1A FBXO28 DLG1 TAF4 NPAT SIRT1 TRIM33 ARID2 IPO13 SMARCC2 RPA1 SPEN | 8.66e-05 | 341 | 247 | 14 | int:NUP50 |
| Interaction | FOXP3 interactions | HDAC9 GATAD2A RRM2 ARID1A MIDEAS MYEF2 FBXO28 CNOT3 NOVA1 ZBTB33 GTSE1 SIRT1 PHC2 BAZ1A SMARCC2 RPA1 | 9.21e-05 | 432 | 247 | 16 | int:FOXP3 |
| Interaction | SIRT6 interactions | CCNDBP1 MED14 ZNF318 QRICH1 RRM2 ARID1A TRIP12 MYEF2 UBR5 FAT4 EP400 WEE1 LMTK2 LRCH3 PCF11 ARID2 MDC1 SMARCC2 USP54 CDH1 | 1.01e-04 | 628 | 247 | 20 | int:SIRT6 |
| Interaction | ERG interactions | NCOA6 HIVEP1 ARID1A MIDEAS TRIP12 UBR5 PRRC2B BICRA TRIM33 ZFHX4 SMARCC2 | 1.01e-04 | 223 | 247 | 11 | int:ERG |
| Interaction | ELK3 interactions | 1.17e-04 | 120 | 247 | 8 | int:ELK3 | |
| Interaction | SMARCC2 interactions | GATAD2A ARID1A MEN1 FBXO28 NOVA1 BICRA SIX1 TRIM33 ZNF341 BAZ1A ARID2 MDC1 SMARCC2 RPA1 | 1.25e-04 | 353 | 247 | 14 | int:SMARCC2 |
| Interaction | YWHAB interactions | HIVEP1 SEC24A LRRK2 SIK1 IRS1 ITGA4 WNK1 TRIP12 FAM117A PIK3C2B SUCO WEE1 GNPTAB EPB41L5 BCAR1 DENND4C TRIM33 DCP1B LMO7 MTOR USP54 PEAK1 RAPGEF2 RPA1 CDH1 HTT OTOG | 1.31e-04 | 1014 | 247 | 27 | int:YWHAB |
| Interaction | MAPK1 interactions | TPR UBE4B LRRK2 IRS1 DCC RRM2 PGR MRTFB UBR5 XPO6 SYNE2 FERMT2 GNPTAB EPB41L5 IFI35 MTOR RPA1 HTT | 1.37e-04 | 543 | 247 | 18 | int:MAPK1 |
| Interaction | SOX6 interactions | 1.41e-04 | 157 | 247 | 9 | int:SOX6 | |
| Interaction | MKI67 interactions | HDAC9 EPC2 STK36 NCOA6 QRICH1 MEN1 UTRN EP400 PNN SMARCAL1 HAUS5 OAS3 MDC1 STAU2 LTBR RPA1 SPEN CDH1 ATP2A2 HCFC1 | 1.53e-04 | 648 | 247 | 20 | int:MKI67 |
| Interaction | SSU72 interactions | 1.57e-04 | 66 | 247 | 6 | int:SSU72 | |
| Interaction | FOXL1 interactions | ZNF536 HIVEP1 STAG1 MIDEAS NOVA1 ZFHX4 BAZ1A SIX5 ZFHX3 YY1AP1 | 1.59e-04 | 196 | 247 | 10 | int:FOXL1 |
| Interaction | PHIP interactions | 1.66e-04 | 197 | 247 | 10 | int:PHIP | |
| Interaction | NCOR1 interactions | HDAC9 PGR MEN1 ZBTB33 KLF15 SIRT1 TRIM33 BAZ1A SEC23IP SMARCC2 RPA1 SPEN HCFC1 HTT | 1.67e-04 | 363 | 247 | 14 | int:NCOR1 |
| Interaction | MBD2 interactions | 1.71e-04 | 161 | 247 | 9 | int:MBD2 | |
| Interaction | GCM1 interactions | 1.85e-04 | 68 | 247 | 6 | int:GCM1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.47e-07 | 15 | 161 | 5 | 529 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZHX3 BNC2 ZNF536 ZBTB38 HIVEP1 ZSCAN9 ZNF318 ZKSCAN5 PRDM10 PLAG1 ATMIN ZBTB33 ZNF628 ADNP2 KLF15 ZHX2 ZNF341 ZFHX3 | 7.39e-05 | 718 | 161 | 18 | 28 |
| GeneFamily | Parkinson disease associated genes | 3.56e-04 | 16 | 161 | 3 | 672 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 5.13e-04 | 18 | 161 | 3 | 1160 | |
| GeneFamily | SINE class homeoboxes | 1.15e-03 | 6 | 161 | 2 | 525 | |
| GeneFamily | PHD finger proteins | 1.26e-03 | 90 | 161 | 5 | 88 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.26e-03 | 53 | 161 | 4 | 532 | |
| GeneFamily | PDZ domain containing | 2.42e-03 | 152 | 161 | 6 | 1220 | |
| GeneFamily | Cyclins|Mediator complex | 3.11e-03 | 33 | 161 | 3 | 1061 | |
| GeneFamily | Fibronectin type III domain containing | 3.12e-03 | 160 | 161 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.22e-03 | 161 | 161 | 6 | 593 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 HIVEP1 STAG1 SEC24A ZMYND8 IRS1 TRIP12 UBR5 XPO6 PRRC2C SYNE2 SEC24B DLG1 TAF4 FERMT2 SUCO MED13 ADGRA3 NPAT MED13L ZHX2 ADGRG6 PCF11 TRIM33 BAZ1A STAU2 OTUD4 ZFHX3 RAPGEF2 SPEN | 7.66e-10 | 856 | 248 | 30 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZHX3 HIVEP1 STAG1 SEC24A ZMYND8 IRS1 TRIP12 UBR5 PRRC2C SEC24B TAF4 FERMT2 MED13 MED13L ZHX2 ADGRG6 TRIM33 BAZ1A STAU2 RAPGEF2 SPEN | 4.34e-09 | 466 | 248 | 21 | M13522 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ZMYND8 IRS1 ZNF318 UBR5 FERMT2 SUCO NPAT WEE1 MED13L ZHX2 PHC2 PCF11 BAZ1A MDC1 OTUD4 RAPGEF2 SPEN | 4.79e-09 | 300 | 248 | 17 | M8702 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | ZHX3 KMT2B UBE4B ARID1A WNK1 PRDM10 PRRC2C UTRN MED13 TRIM33 ATP2A2 HCFC1 | 1.61e-07 | 180 | 248 | 12 | M8239 |
| Coexpression | GSE17721_CTRL_VS_LPS_12H_BMDC_UP | GON4L TOMM20 SIK1 ZNF318 PROM1 CENPT TTYH2 ATF6 EEPD1 CKAP2 HCFC1 | 3.35e-06 | 199 | 248 | 11 | M3701 |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | LIN54 MED14 MYEF2 NPAT ZBTB33 FLVCR1 SUCNR1 SIRT1 DENND4C ARID2 PRORP | 3.51e-06 | 200 | 248 | 11 | M9777 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | HDAC9 CCNDBP1 LIN54 ZMYND8 NFASC TOMM20 SIK1 IRS1 DCC LIN9 PRRC2C PCDH19 ANKRD12 SDC1 ATMIN COL6A3 VPS37A PNN COL27A1 GNPTAB TTYH2 KIAA1549 SCAMP2 BCAR1 ZFHX3 CEP295 HTT | 6.57e-06 | 1102 | 248 | 27 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | HDAC9 CCNDBP1 LIN54 ZMYND8 NFASC TOMM20 SIK1 IRS1 DCC LIN9 PRRC2C PCDH19 ANKRD12 SDC1 ATMIN COL6A3 VPS37A PNN COL27A1 GNPTAB TTYH2 KIAA1549 SCAMP2 BCAR1 ZFHX3 CEP295 HTT | 9.38e-06 | 1124 | 248 | 27 | MM1070 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | EPHX2 ZHX3 KMT2B UBE4B GON4L DCC PRRC2C OSBPL1A COL27A1 KIAA1549 TNRC6C TENM4 CCAR1 ATP2A2 CFAP46 | 1.17e-05 | 417 | 248 | 15 | M39224 |
| Coexpression | GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN | 1.72e-05 | 194 | 248 | 10 | M5767 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | ZMYND8 MRTFB OSBPL1A DLG1 UTRN ADGRA3 ADNP2 MED13L STAU2 OTUD4 | 1.97e-05 | 197 | 248 | 10 | M7403 |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | EPHX2 SSR1 OPRPN FAM117A DLG1 CNOT3 CENPT UBE3B SMARCC2 SPEN | 2.15e-05 | 199 | 248 | 10 | M3257 |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | RRM2 TBATA OSBPL1A PLTP MED13 WEE1 POU6F1 TENM4 SMARCC2 CKAP2 | 2.15e-05 | 199 | 248 | 10 | M6198 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN | NCOA6 SSR1 FAM117A MRTFB PIK3C2B TMEM177 CSF2RB MDC1 LRCH4 YY1AP1 | 2.15e-05 | 199 | 248 | 10 | M7711 |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP | BHLHE41 UBE4B TOMM20 XYLT1 PRDM10 PIK3C2B NFRKB PNN LMTK2 MED13L | 2.24e-05 | 200 | 248 | 10 | M7594 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | BHLHE41 MAN2C1 GON4L IRS1 MAGI2 PROM1 KAT2B FAM117A MRTFB SYNE2 FBXO7 MLLT6 GNAS ECM2 EPB41L5 MED13L LRCH3 HIPK3 ARID2 ZFHX3 USP54 | 3.09e-05 | 807 | 248 | 21 | M16651 |
| Coexpression | NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 3.40e-05 | 95 | 248 | 7 | M41179 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | IRS1 DCC RRM2 FREM1 PROM1 FREM2 SYNE2 SDC1 FOXM1 WEE1 GTSE1 TENM4 CKAP2 | 3.63e-05 | 354 | 248 | 13 | M39061 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | BHLHE41 HDAC9 ZHX3 TBC1D9B ZBTB38 NFASC TOMM20 ZNF318 KAT2B SYNE2 FBXO7 ANKRD12 GNAS SUCO UTRN PRRC2B VPS37A ZBTB33 PCLO PHC2 ATF6 USF3 DIP2C | 3.70e-05 | 946 | 248 | 23 | M39169 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 4.84e-05 | 176 | 248 | 9 | M39223 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | MAN2C1 UBE4B SEC24A FBXO28 DLG1 CNOT3 NPAT UBE3B GNPTAB DCLRE1B PCF11 HIPK3 ARAP3 BAZ1A SMARCC2 | 5.49e-05 | 477 | 248 | 15 | M40930 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN | 6.26e-05 | 72 | 248 | 6 | M40882 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 7.50e-05 | 145 | 248 | 8 | M1810 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | BNC2 ZNF536 ITGA4 RRM2 PROM1 FREM2 SNX8 SORCS2 PLAG1 GNAS UTRN SDC1 PLTP FAT4 CD248 COL27A1 CHST8 ADGRG6 COL18A1 TENM4 CSPG4 LTBR IGSF21 CDH1 | 9.31e-05 | 1074 | 248 | 24 | M1941 |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | ZHX3 ZMYND8 SEC24B PLA2G6 FERMT2 PNN WEE1 PHC2 RAPGEF2 SPEN ATP2A2 | 1.05e-04 | 289 | 248 | 11 | M13630 |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 1.15e-04 | 197 | 248 | 9 | M8464 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP | 1.20e-04 | 198 | 248 | 9 | M5215 | |
| Coexpression | GSE4142_NAIVE_VS_GC_BCELL_UP | 1.24e-04 | 199 | 248 | 9 | M6375 | |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP | 1.24e-04 | 199 | 248 | 9 | M5759 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_HSC_UP | 1.29e-04 | 200 | 248 | 9 | M7040 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 1.29e-04 | 200 | 248 | 9 | M7532 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_UP | TBC1D9B GATAD2A IRS1 ZKSCAN5 ADGRA3 POM121L2 PHC2 CKAP2 ANKRD34C | 1.29e-04 | 200 | 248 | 9 | M5367 |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 1.29e-04 | 200 | 248 | 9 | M5261 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.45e-04 | 250 | 248 | 10 | M11318 | |
| Coexpression | FISCHER_DREAM_TARGETS | GATAD2A STAG1 MARS1 LIN54 RRM2 LIN9 NPAT FOXM1 PNN WEE1 MYO19 GTSE1 HAUS5 TMEM39B DCLRE1B RFWD3 PCF11 ARID2 MDC1 CEP295 CKAP2 HCFC1 | 1.47e-04 | 969 | 248 | 22 | M149 |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D4 | 1.58e-04 | 54 | 248 | 5 | M15468 | |
| Coexpression | SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP | ZHX3 SSR1 RRM2 TRIP12 PLAG1 GNAS FERMT2 OAS3 SCAMP2 RFWD3 SMARCC2 HCFC1 | 1.62e-04 | 356 | 248 | 12 | M41052 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | NCOA6 ZBTB38 TOMM20 RRM2 ARID1A KAT2B SYNE2 KIAA1958 GNAS SDC1 FOXM1 TTYH2 PHC2 ADGRG6 TRIM33 USF3 EEPD1 LTBR ATP2A2 HTT | 1.72e-04 | 845 | 248 | 20 | M18090 |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED | 1.73e-04 | 12 | 248 | 3 | M47998 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR IL16 ZBTB38 CCNDBP1 ITGA4 ARID1A WNK1 TRIP12 KAT2B UBR5 XPO6 MLLT6 GNAS UTRN MED13 PRRC2B NPAT EP400 PNN GNPTAB TNRC6C PCF11 TRIM33 BAZ1A ARID2 OTUD4 CKAP2 RPA1 SPEN | 1.96e-04 | 1492 | 248 | 29 | M40023 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TPR ZHX3 CCNDBP1 ZMYND8 UBR5 PRRC2C SYNE2 GNAS PLTP ADGRA3 ATMIN GNPTAB TRIM33 COL18A1 BAZ1A CSPG4 LTBR CDH1 ATP2A2 | 2.05e-04 | 790 | 248 | 19 | M12490 |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | ZHX3 TBC1D9B NFASC ITGA4 XYLT1 PLA2G6 SDC1 EP400 ECM2 SIX1 IFI35 PCF11 LMO7 ZFHX3 | 2.21e-04 | 482 | 248 | 14 | M12144 |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D | EPHX2 ZBTB38 KMT2B STAG1 UBE4B MARS1 ZMYND8 KAT2B UBR5 SEC24B PLA2G6 ILVBL BAHCC1 TTYH2 KLF15 POU6F1 BCAR1 TENM4 CSPG4 HCFC1 | 2.33e-04 | 865 | 248 | 20 | M2417 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | NCOA6 STAG1 MED14 TRIP12 MRTFB FBXO28 SEC24B OSBPL1A DLG1 ATMIN DENND4C SEC23IP RPA1 | 2.46e-04 | 429 | 248 | 13 | M29 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | LIN54 RRM2 MYEF2 SYNE2 DLG1 MED13 ILVBL NPAT FOXM1 CENPT CD248 WEE1 RANBP3 MYO19 GTSE1 HAUS5 RFWD3 ARID2 INTS4 CEP295 CKAP2 | 2.55e-04 | 939 | 248 | 21 | M45768 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | CACUL1 STAG1 SIK1 IRS1 EXT2 ARID1A WNK1 NDUFS1 FBXO7 GNAS SDK1 SDC1 PRRC2B POMT2 WEE1 MED13L RBM20 CHST8 TMEM177 COL18A1 ATF6 ATP2A2 | 2.58e-04 | 1009 | 248 | 22 | M157 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP | 2.64e-04 | 174 | 248 | 8 | M1113 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | CACUL1 UBE4B QRICH1 ARID1A PRDM10 NFRKB ADGRA3 NPAT TMEM39B SIRT1 PHC2 PCF11 TENM4 MTOR SEC23IP IPO13 INTS4 CEP295 SPEN | 2.67e-04 | 807 | 248 | 19 | M14594 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | RRM2 FREM1 PROM1 FREM2 SDC1 FOXM1 WEE1 GTSE1 TENM4 ZFHX3 CKAP2 | 2.69e-04 | 322 | 248 | 11 | M39060 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.72e-04 | 221 | 248 | 9 | M39222 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | KMT2B ZMYND8 EXT2 ARID1A MEN1 PCDH19 SUCO SDC1 CNOT3 ILVBL ADGRA3 POMT2 LMTK2 SCAMP2 ATF6B ATP2A2 HTT | 2.89e-04 | 681 | 248 | 17 | M5314 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP | 2.96e-04 | 177 | 248 | 8 | MM479 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D | EPHX2 ZBTB38 KMT2B STAG1 UBE4B MARS1 ZMYND8 KAT2B UBR5 SEC24B PLA2G6 ILVBL BAHCC1 TTYH2 KLF15 POU6F1 BCAR1 TENM4 CSPG4 HCFC1 | 3.27e-04 | 888 | 248 | 20 | MM1315 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TPR EPC2 HIVEP1 CACUL1 TRO MED14 WNK1 ZKSCAN5 LIN9 NDUFS1 XPO6 SEC24B DLG1 UTRN ADGRA3 NPAT ZBTB33 WEE1 SIRT1 TRIM33 ARID2 MDC1 ZFHX3 CKAP2 RAPGEF2 RPA1 | 2.21e-09 | 564 | 245 | 26 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | EPC2 TRO SEC24A MED14 ARID1A WNK1 ZKSCAN5 LIN9 NDUFS1 SYNE2 SEC24B DLG1 ADGRA3 ZBTB33 CENPT PNN WEE1 SIRT1 ADGRG6 TRIM33 BAZ1A CCAR1 SMARCC2 CEP295 CKAP2 RAPGEF2 | 2.07e-08 | 629 | 245 | 26 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | EPC2 ZNF536 TRO SEC24A MED14 ARID1A WNK1 LIN9 PROM1 FBXO28 SYNE2 DLG1 SDK1 NOVA1 ZBTB33 CENPT WEE1 PCLO EPB41L5 SIRT1 TRIM33 MDC1 CEP295 CKAP2 RAPGEF2 | 2.87e-08 | 595 | 245 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR EPC2 CACUL1 TRO ARID1A WNK1 ZKSCAN5 DLG1 PNN SIRT1 ZFHX4 BAZ1A STAU2 CCAR1 SMARCC2 CEP295 PEAK1 | 1.22e-05 | 432 | 245 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | BHLHE41 TPR EPC2 BNC2 NCOA6 ZNF536 IL16 LIN54 ARID1A LIN9 FREM1 PROM1 XPO6 SYNE2 ANKRD12 VPS37A ZBTB33 SGIP1 PNN GNPTAB KIAA1549 SIRT1 CHST8 LRCH3 TRIM33 BAZ1A STAU2 CCAR1 SMARCC2 ZFHX3 CEP295 RPA1 | 2.05e-05 | 1252 | 245 | 32 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | ZNF536 PROM1 UBR5 PIK3C2B NOVA1 PCLO EPB41L5 RFWD3 DCP1B STON2 CDH1 | 8.18e-05 | 231 | 245 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | HDAC9 ZHX3 MED14 GPR87 FREM1 MAGI2 FREM2 PLAG1 SUCO UTRN SDC1 MED13 FAT4 ADAMTSL1 SGIP1 KIAA1549 TNRC6C MED13L SIX1 ZFHX4 LMO7 ZFHX3 | 8.98e-05 | 769 | 245 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.30e-04 | 203 | 245 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | TPR STAG1 MED14 IRS1 LRCH1 LIN9 PRDM10 FBXO28 ANKRD12 NPAT GNPTAB TRIM33 ARID2 CEP295 | 3.46e-12 | 186 | 251 | 14 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 RGS22 DCC FREM1 FREM2 PTPRQ USH2A SDK1 FAT4 PCLO TENM4 ZFHX4 OTOG | 4.60e-11 | 184 | 251 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 RGS22 DCC FREM1 FREM2 PTPRQ USH2A SDK1 FAT4 PCLO TENM4 ZFHX4 OTOG | 4.60e-11 | 184 | 251 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 RGS22 DCC FREM1 FREM2 PTPRQ USH2A SDK1 FAT4 PCLO TENM4 ZFHX4 OTOG | 4.60e-11 | 184 | 251 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | ZNF536 ARID1A WNK1 XYLT1 UTRN FAT4 WEE1 ADNP2 KIAA1549 MED13L ZFHX4 HCFC1 | 1.60e-09 | 199 | 251 | 12 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | NCOA6 ZBTB38 KAT2B SYNE2 UTRN OAS3 SCAMP2 ATF6B SEC23IP INTS4 RPA1 | 6.73e-09 | 180 | 251 | 11 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | NCOA6 ZBTB38 KAT2B SYNE2 UTRN OAS3 SCAMP2 ATF6B SEC23IP INTS4 RPA1 | 6.73e-09 | 180 | 251 | 11 | 703a1d0f9536af94d56757eb01221878d7b7fe61 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | HIVEP1 WNK1 UBR5 PRRC2C DLG1 PLAG1 UTRN SDK1 MED13 MED13L ARID2 | 1.39e-08 | 193 | 251 | 11 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | BHLHE41 HDAC9 LIN54 XYLT1 FHIP1A REP15 DCP1B LMO7 INTS4 IGSF21 | 3.00e-08 | 162 | 251 | 10 | d0ffebf5adee8a3ac9b81a4b793184f54010489a |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | LIN9 PCDH19 GNAS SGIP1 ECM2 ADGRG6 CSPG4 ZFHX3 CKAP2 RAPGEF2 | 6.23e-08 | 175 | 251 | 10 | 3e56695a9db97cb1d3503425c48eb79bbf99213e |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.48e-08 | 183 | 251 | 10 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.98e-08 | 184 | 251 | 10 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-07 | 185 | 251 | 10 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-07 | 185 | 251 | 10 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LRRK2 FREM2 SORCS2 FHIP1A SDC1 ADAMTSL1 EPB41L5 LMO7 USP54 CDH1 | 1.10e-07 | 186 | 251 | 10 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SYNE2 SORCS2 UTRN FHIP1A EPB41L5 IQCA1 LMO7 UNC5CL USP54 CDH1 | 1.16e-07 | 187 | 251 | 10 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | NFASC COL6A3 SGIP1 CD248 TTYH2 BCAR1 ADGRG6 COL18A1 CSPG4 DGKI | 1.16e-07 | 187 | 251 | 10 | a2bf958ea59c359a265bfa437d59315e1920cdd4 |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | BNC2 ZNF536 IRS1 ADGRA3 NOVA1 COL6A3 FAT4 COL27A1 ADGRG6 TENM4 | 1.28e-07 | 189 | 251 | 10 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LRRK2 FREM2 PTPRQ SORCS2 FHIP1A ADAMTSL1 EPB41L5 LMO7 USP54 CDH1 | 1.35e-07 | 190 | 251 | 10 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-07 | 191 | 251 | 10 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.48e-07 | 192 | 251 | 10 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | STAG1 MAGI2 DLG1 SDK1 FHIP1A EPB41L5 MED13L DIP2C PEAK1 RAPGEF2 | 1.98e-07 | 198 | 251 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 ADGRA3 NOVA1 COL6A3 FAT4 COL27A1 ITGA10 TENM4 ZFHX4 ZFHX3 | 2.07e-07 | 199 | 251 | 10 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.17e-07 | 200 | 251 | 10 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.17e-07 | 200 | 251 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | FERMT2 PLTP COL6A3 SGIP1 CD248 TTYH2 BCAR1 ADGRG6 COL18A1 CSPG4 | 2.17e-07 | 200 | 251 | 10 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | FERMT2 PLTP COL6A3 SGIP1 CD248 TTYH2 BCAR1 ADGRG6 COL18A1 CSPG4 | 2.17e-07 | 200 | 251 | 10 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | FERMT2 PLTP COL6A3 SGIP1 CD248 TTYH2 BCAR1 ADGRG6 COL18A1 CSPG4 | 2.17e-07 | 200 | 251 | 10 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.48e-07 | 166 | 251 | 9 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.48e-07 | 166 | 251 | 9 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.34e-07 | 173 | 251 | 9 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.43e-07 | 179 | 251 | 9 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.84e-07 | 180 | 251 | 9 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.84e-07 | 180 | 251 | 9 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | BHLHE41 EPHX2 ZNF536 SORCS2 COL27A1 COL18A1 ZFHX4 CSPG4 IGSF21 | 8.84e-07 | 180 | 251 | 9 | 1e819c5c87704ec6535dfeaae56561895e239d07 |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-06 | 186 | 251 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.21e-06 | 187 | 251 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 187 | 251 | 9 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.27e-06 | 188 | 251 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 188 | 251 | 9 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 188 | 251 | 9 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.33e-06 | 189 | 251 | 9 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.38e-06 | 190 | 251 | 9 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.40e-06 | 141 | 251 | 8 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-06 | 191 | 251 | 9 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-06 | 192 | 251 | 9 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.58e-06 | 193 | 251 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.58e-06 | 193 | 251 | 9 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.58e-06 | 193 | 251 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-06 | 193 | 251 | 9 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 193 | 251 | 9 | 7386fadc13a437f3b0c99b5d116cd3c5f893529c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-06 | 194 | 251 | 9 | 3b9ada901dfe7a5cc4861a883d3268c53b11e5b6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.72e-06 | 195 | 251 | 9 | 6e875c83f838241b5fcaf4a3249b1408d74521dc | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | NFASC XYLT1 SDK1 COL6A3 ADAMTSL1 SGIP1 COL27A1 COL18A1 ZFHX4 | 1.72e-06 | 195 | 251 | 9 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-06 | 195 | 251 | 9 | 815ac5dacd382b11abb32011ed1c0635b0ddc779 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-06 | 196 | 251 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-06 | 196 | 251 | 9 | 624f700daea48d9bad4cc554f4776bd809ae1e54 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 196 | 251 | 9 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-06 | 197 | 251 | 9 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.87e-06 | 197 | 251 | 9 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.87e-06 | 197 | 251 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.95e-06 | 198 | 251 | 9 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | ADGRA3 COL6A3 FAT4 ADAMTSL1 SGIP1 COL27A1 ADGRG6 COL18A1 DIP2C | 2.03e-06 | 199 | 251 | 9 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.03e-06 | 199 | 251 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-06 | 199 | 251 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.03e-06 | 199 | 251 | 9 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.03e-06 | 199 | 251 | 9 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.11e-06 | 200 | 251 | 9 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.11e-06 | 200 | 251 | 9 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.11e-06 | 200 | 251 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.11e-06 | 200 | 251 | 9 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.17e-06 | 168 | 251 | 8 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.65e-06 | 170 | 251 | 8 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-06 | 175 | 251 | 8 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-06 | 175 | 251 | 8 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-06 | 175 | 251 | 8 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-06 | 175 | 251 | 8 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-06 | 175 | 251 | 8 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.98e-06 | 175 | 251 | 8 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.98e-06 | 175 | 251 | 8 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-06 | 176 | 251 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.91e-06 | 178 | 251 | 8 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 178 | 251 | 8 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.24e-06 | 179 | 251 | 8 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.24e-06 | 179 | 251 | 8 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.24e-06 | 179 | 251 | 8 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.58e-06 | 180 | 251 | 8 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.94e-06 | 181 | 251 | 8 | be4f35c9eb5b3083acb2264128f095fac1f3da45 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.30e-06 | 182 | 251 | 8 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.68e-06 | 183 | 251 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 184 | 251 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.09e-05 | 186 | 251 | 8 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 186 | 251 | 8 | 722da08cd978249a19855fd3ec8ddda780c99d83 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 186 | 251 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 186 | 251 | 8 | c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 187 | 251 | 8 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 187 | 251 | 8 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-05 | 187 | 251 | 8 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 187 | 251 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.17e-05 | 135 | 251 | 7 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ZMYND8 IRS1 QRICH1 ARID1A MRTFB FBXO28 SEC24B TAF4 MED13 ADNP2 MED13L ZHX2 TRIM33 BAZ1A RAPGEF2 SPEN | 1.92e-10 | 182 | 250 | 16 | 3887_DN |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | UBE4B SEC24A ZMYND8 ZNF318 XPO6 MED13 PRRC2B RFWD3 PCF11 TRIM33 BAZ1A DIP2C HCFC1 | 1.63e-07 | 187 | 250 | 13 | 4989_DN |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | ZMYND8 ZNF318 WNK1 XPO6 FERMT2 EP400 RANBP3 SMARCAL1 DENND4C RFWD3 TRIM33 SEC23IP HCFC1 | 2.50e-07 | 194 | 250 | 13 | 1670_DN |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | ZMYND8 IRS1 ARID1A MRTFB FBXO28 SEC24B ANKRD12 NPAT ADNP2 TRIM33 BAZ1A RAPGEF2 | 7.69e-07 | 180 | 250 | 12 | 4541_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | STAG1 ZMYND8 MRTFB UBR5 SEC24B DLG1 MED13L ZHX2 TRIM33 BAZ1A RAPGEF2 CDH1 | 9.17e-07 | 183 | 250 | 12 | 7498_DN |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ZMYND8 IRS1 ARID1A MRTFB SEC24B TAF4 NPAT ADNP2 ZHX2 SIRT1 TRIM33 RAPGEF2 | 9.71e-07 | 184 | 250 | 12 | 2321_DN |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | ZMYND8 IRS1 ARID1A MRTFB TAF4 WEE1 ZHX2 SIRT1 PCF11 TMEM177 TRIM33 RAPGEF2 | 1.15e-06 | 187 | 250 | 12 | 7080_DN |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; HL60; HG-U133A | KMT2B STAG1 MED14 SSR1 ITGA4 CIZ1 DLG1 TAF4 PCF11 TMEM177 ATF6 STAU2 | 2.21e-06 | 199 | 250 | 12 | 1559_DN |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | TPR ZBTB38 WNK1 PRRC2C FERMT2 PCLO GTSE1 BAZ1A SMARCC2 RAPGEF2 SPEN | 4.65e-06 | 178 | 250 | 11 | 3998_DN |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | BHLHE41 SEC24A ZMYND8 ZNF318 MRTFB TAF4 NPAT GTSE1 PCF11 TRIM33 DIP2C | 5.46e-06 | 181 | 250 | 11 | 1791_DN |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ZBTB38 ZMYND8 GON4L WNK1 DLG1 GTSE1 MED13L SIX1 ATF6 SEC23IP SPEN | 6.07e-06 | 183 | 250 | 11 | 1709_DN |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; HL60; HG-U133A | HDAC9 TPR HIVEP1 MED14 ITGA4 FASTK ANKRD12 SUCO WEE1 ATF6 SEC23IP | 9.12e-06 | 191 | 250 | 11 | 1418_DN |
| Drug | Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A | KMT2B GATAD2A PLA2G6 UTRN CENPT RANBP3 HAUS5 ITGA10 MED13L CHST8 DIP2C | 1.06e-05 | 194 | 250 | 11 | 1812_UP |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | ZHX3 TBC1D9B HIVEP1 KMT2B ZNF318 WNK1 PIK3C2B OSBPL1A RANBP3 SEC23IP HCFC1 | 1.16e-05 | 196 | 250 | 11 | 1174_DN |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A | TBC1D9B ARID1A PIK3C2B PGLS ANKRD12 PRRC2B WEE1 RANBP3 SMARCAL1 GNPTAB GTSE1 | 1.22e-05 | 197 | 250 | 11 | 2034_DN |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | UBE4B MARS1 MED14 UTRN RANBP3 HAUS5 OAS3 HIPK3 TRIM33 ATF6 HCFC1 | 1.28e-05 | 198 | 250 | 11 | 1503_DN |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; HL60; HG-U133A | ZNF536 STAG1 SSR1 OSBPL1A CIZ1 PRRC2B NPAT EP400 UBE3B MED13L HCFC1 | 1.34e-05 | 199 | 250 | 11 | 1751_DN |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; HL60; HG-U133A | UBE4B ZSCAN9 MED14 PIK3C2B BICRA UBE3B OVGP1 IFT52 LTBR RAPGEF2 HCFC1 | 1.34e-05 | 199 | 250 | 11 | 1753_DN |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HG-U133A | IL16 ZBTB38 STAG1 ITGA4 ARID1A ZKSCAN5 OPRPN PRDM10 DENND4C HIPK3 DIP2C | 1.41e-05 | 200 | 250 | 11 | 409_DN |
| Drug | 3-methyladenine | 1.78e-05 | 134 | 250 | 9 | CID000001673 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | BNC2 MRTFB UBR5 SEC24B ANKRD12 MED13L TRIM33 TENM4 ZFHX4 RAPGEF2 | 2.04e-05 | 171 | 250 | 10 | 7535_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.15e-05 | 172 | 250 | 10 | 1072_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | HIVEP1 STAG1 MRTFB UBR5 ANKRD12 NPAT MED13L ZHX2 TRIM33 RAPGEF2 | 2.38e-05 | 174 | 250 | 10 | 7530_DN |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | ZBTB38 HIVEP1 STAG1 IRS1 ARID1A LRCH1 MED13L SIX1 ZHX2 ZFHX3 | 2.75e-05 | 177 | 250 | 10 | 6434_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.89e-05 | 178 | 250 | 10 | 1112_DN | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | HIVEP1 STAG1 ARID1A DLG1 ANKRD12 FOXM1 RANBP3 GTSE1 SEC23IP HTT | 4.81e-05 | 189 | 250 | 10 | 2041_DN |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | BHLHE41 TBC1D9B KMT2B UBE4B ZNF318 SSR1 PIK3C2B HAUS5 TMEM177 SEC23IP | 5.25e-05 | 191 | 250 | 10 | 7397_DN |
| Drug | Thimerosal | TPR STAG1 GON4L DCC WNK1 LIN9 MAGI2 KAT2B PRRC2C SYNE2 FBXO7 PGLS DLG1 SDC1 MED13 NPAT EP400 PCLO TTYH2 EPB41L5 KLF15 MED13L ARAP3 STON2 OTUD4 SMARCC2 SIX5 RAPGEF2 SPEN | 5.83e-05 | 1199 | 250 | 29 | ctd:D013849 |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | 6.25e-05 | 195 | 250 | 10 | 2956_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A | GATAD2A UBE4B NFRKB PLTP BAHCC1 RANBP3 MED13L RFWD3 BAZ1A HCFC1 | 6.53e-05 | 196 | 250 | 10 | 1156_DN |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | WNK1 NACAD NFRKB FERMT2 GNPTAB ITGA10 OAS3 HIPK3 OVGP1 ZFHX4 | 7.10e-05 | 198 | 250 | 10 | 2841_UP |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A_EA | UBE4B MED14 SSR1 WNK1 SEC24B CIZ1 CNOT3 ILVBL COL18A1 SEC23IP | 7.10e-05 | 198 | 250 | 10 | 1042_DN |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | HIVEP1 UBE4B SEC24A WNK1 RANBP3 COL18A1 ATF6 TENM4 MTOR RAPGEF2 | 7.10e-05 | 198 | 250 | 10 | 6287_DN |
| Disease | vital capacity | HDAC9 BNC2 NCOA6 ZBTB38 DCC TRIP12 PIK3C2B DLG1 PLAG1 UTRN DAGLA COL6A3 ADAMTSL1 ZNF628 RANBP3 PCLO POM121L2 VTA1 SIX1 ZHX2 RBM20 ADGRG6 ZNF341 OTUD4 ZFHX3 ATP2A2 OTOG | 5.36e-06 | 1236 | 246 | 27 | EFO_0004312 |
| Disease | mean corpuscular hemoglobin concentration | HDAC9 ZHX3 GATAD2A LIN54 GON4L ZNF318 MIDEAS LIN9 KAT2B FAM117A UBR5 FBXO7 ANKRD12 MED13 ATMIN EP400 POU6F1 TRIM33 BAZ1A RP1L1 OTUD4 LTBR RPA1 CDH1 | 2.02e-05 | 1105 | 246 | 24 | EFO_0004528 |
| Disease | obsolete_red blood cell distribution width | KMT2B GATAD2A LIN54 ITGAD WNK1 MIDEAS LRCH1 LIN9 FAM117A PRRC2C SYNE2 NFRKB FBXO7 PLA2G6 ANKRD12 DAGLA PLTP EP400 MYO19 UBE3B SCAMP2 DENND4C TRIM33 EEPD1 RP1L1 NUTM2F CDH1 | 2.47e-05 | 1347 | 246 | 27 | EFO_0005192 |
| Disease | risk-taking behaviour | BNC2 ZNF536 HIVEP1 STAG1 NFASC DCC MAGI2 SORCS2 SDK1 BAHCC1 SGIP1 POM121L2 PHC2 TENM4 RP1L1 LRCH4 DGKI ZFHX3 HTT | 2.54e-05 | 764 | 246 | 19 | EFO_0008579 |
| Disease | Colorectal Carcinoma | CACUL1 GPR87 DCC RRM2 ARID1A WNK1 PROM1 SNX8 GNAS CD248 CHST8 OVGP1 ARAP3 LMO7 CCAR1 DIP2C IGSF21 CDH1 | 2.80e-05 | 702 | 246 | 18 | C0009402 |
| Disease | neuroticism measurement | BNC2 ZNF536 HIVEP1 STAG1 TRO ZMYND8 QRICH1 ACVRL1 DCC SORCS2 DAGLA SDK1 PCLO UBE3B LMTK2 POM121L2 ATF6B RP1L1 DIP2C DGKI IGSF21 | 2.80e-05 | 909 | 246 | 21 | EFO_0007660 |
| Disease | red blood cell density measurement | STK36 HIVEP1 LIN54 SSR1 ACVRL1 WNK1 KAT2B UBR5 SORCS2 FBXO7 PLA2G6 PLTP EP400 FLVCR1 EPB41L5 PHC2 TRIM33 BAZ1A ARID2 OTUD4 | 5.46e-05 | 880 | 246 | 20 | EFO_0007978 |
| Disease | depressive symptom measurement | HDAC9 ZHX3 BNC2 HIVEP1 ZMYND8 DCC SYNE2 DAGLA SDK1 SGIP1 PCLO UBE3B POM121L2 | 6.68e-05 | 426 | 246 | 13 | EFO_0007006 |
| Disease | body fat percentage | BNC2 ZBTB38 HIVEP1 STAG1 IRS1 TRIP12 ZKSCAN5 MAGI2 DLG1 PLA2G6 PRRC2B ZFHX3 RPA1 HTT | 6.81e-05 | 488 | 246 | 14 | EFO_0007800 |
| Disease | 1-stearoylglycerol 1-monostearin measurement | 6.92e-05 | 2 | 246 | 2 | EFO_0021111 | |
| Disease | salivary gland cancer (implicated_via_orthology) | 6.92e-05 | 2 | 246 | 2 | DOID:8850 (implicated_via_orthology) | |
| Disease | Marles Greenberg Persaud syndrome | 6.92e-05 | 2 | 246 | 2 | C1855425 | |
| Disease | wellbeing measurement | BNC2 HIVEP1 STAG1 ZMYND8 LRRK2 ACVRL1 DCC PTPRQ DAGLA SDK1 FAT4 PCLO UBE3B POM121L2 ADGRG6 RP1L1 ZFHX3 | 7.89e-05 | 692 | 246 | 17 | EFO_0007869 |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 9.67e-05 | 88 | 246 | 6 | EFO_0000341, EFO_0006527 | |
| Disease | mean reticulocyte volume | HDAC9 GATAD2A TRO ZNF318 ITGA4 KAT2B FAM117A FBXO7 TAF4 EP400 ZHX2 TRIM33 IFT52 MTOR SEC23IP OTUD4 INTS4 RPA1 | 1.44e-04 | 799 | 246 | 18 | EFO_0010701 |
| Disease | Coffin-Siris syndrome | 1.54e-04 | 13 | 246 | 3 | C0265338 | |
| Disease | testosterone measurement | ZHX3 NCOA6 ZNF536 SPEM3 STAG1 MARS1 ZNF318 ARID1A MIDEAS ZKSCAN5 KAT2B FAM186A SYNE2 TAF4 USH2A UTRN SDC1 FOXM1 ZFHX4 SEC23IP DGKI ZFHX3 YY1AP1 EDA2R | 1.84e-04 | 1275 | 246 | 24 | EFO_0004908 |
| Disease | Abnormality of refraction | ZHX3 ZBTB38 TDRD9 TKTL1 MAGI2 FBXO7 PLAG1 PLA2G6 UTRN DAGLA ADAMTSL1 PCLO ARID2 EEPD1 ZFHX3 PEAK1 | 1.86e-04 | 673 | 246 | 16 | HP_0000539 |
| Disease | pathological gambling | 2.07e-04 | 3 | 246 | 2 | EFO_1001926 | |
| Disease | Endocrine System Diseases | 2.07e-04 | 3 | 246 | 2 | C0014130 | |
| Disease | Branchiootorenal Spectrum Disorders | 2.07e-04 | 3 | 246 | 2 | cv:CN043574 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | BNC2 ZBTB38 HIVEP1 STAG1 TRIP12 MAGI2 DLG1 PLA2G6 ZFHX3 RPA1 HTT | 2.63e-04 | 364 | 246 | 11 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Disease | unipolar depression, bipolar disorder | 3.49e-04 | 156 | 246 | 7 | EFO_0003761, MONDO_0004985 | |
| Disease | Dystonia, Limb | 3.57e-04 | 17 | 246 | 3 | C0751093 | |
| Disease | Dystonia, Diurnal | 3.57e-04 | 17 | 246 | 3 | C0393610 | |
| Disease | body surface area | BNC2 ZBTB38 HIVEP1 RRM2 WNK1 TRIP12 PLAG1 PLA2G6 GNAS MED13L ZHX2 ADGRG6 MTOR ZFHX3 RPA1 | 3.59e-04 | 643 | 246 | 15 | EFO_0022196 |
| Disease | forced expiratory volume | HDAC9 BNC2 NCOA6 ZBTB38 TDRD9 DCC PIK3C2B PLAG1 PRRC2B ADAMTSL1 ZNF628 POM121L2 VTA1 ZHX2 RBM20 ADGRG6 OTUD4 | 3.68e-04 | 789 | 246 | 17 | EFO_0004314 |
| Disease | Branchio-Oculo-Facial Syndrome | 4.11e-04 | 4 | 246 | 2 | C0376524 | |
| Disease | Branchiootorenal Syndrome 1 | 4.11e-04 | 4 | 246 | 2 | C4551702 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 4.11e-04 | 4 | 246 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | Branchio-Oto-Renal Syndrome | 4.11e-04 | 4 | 246 | 2 | C0265234 | |
| Disease | Wallerian Degeneration | 4.11e-04 | 4 | 246 | 2 | C0043020 | |
| Disease | Branchiootorenal Syndrome 2 | 4.11e-04 | 4 | 246 | 2 | C1970479 | |
| Disease | Dystonia, Paroxysmal | 4.26e-04 | 18 | 246 | 3 | C0393588 | |
| Disease | obesity (implicated_via_orthology) | 4.71e-04 | 215 | 246 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | cutaneous melanoma | 5.46e-04 | 121 | 246 | 6 | EFO_0000389 | |
| Disease | uric acid measurement | ZHX3 ZNF318 ARID1A ZKSCAN5 KIAA0319 GNAS PRRC2B FAT4 LMTK2 KLF15 UNC5CL DIP2C RPA1 ATP2A2 | 6.58e-04 | 610 | 246 | 14 | EFO_0004761 |
| Disease | pulmonary alveolar proteinosis (implicated_via_orthology) | 6.81e-04 | 5 | 246 | 2 | DOID:12120 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 6.81e-04 | 21 | 246 | 3 | OBA_2045104 | |
| Disease | serum gamma-glutamyl transferase measurement | STAG1 C4orf50 GON4L MAP3K7CL ARID1A KAT2B TAF4 PLTP MED13 BAHCC1 SGIP1 BICRA LMTK2 KLF15 TENM4 RP1L1 YY1AP1 IGSF21 | 7.13e-04 | 914 | 246 | 18 | EFO_0004532 |
| Disease | chronic obstructive pulmonary disease | HDAC9 BNC2 ZBTB38 ZSCAN9 NOVA1 COL6A3 ADAMTSL1 POM121L2 VTA1 ATF6B ADGRG6 TENM4 OTUD4 LTBR ATP2A2 | 7.19e-04 | 688 | 246 | 15 | EFO_0000341 |
| Disease | Malignant neoplasm of prostate | IL16 IRS1 ARID1A CIZ1 CNOT3 LMTK2 KLF15 BCAR1 SIRT1 ARID2 INTS4 ZFHX3 SPEN CDH1 | 7.23e-04 | 616 | 246 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | IL16 IRS1 ARID1A CIZ1 CNOT3 LMTK2 KLF15 BCAR1 SIRT1 ARID2 INTS4 ZFHX3 SPEN CDH1 | 7.23e-04 | 616 | 246 | 14 | C0033578 |
| Disease | fasting blood glucose measurement | 7.27e-04 | 287 | 246 | 9 | EFO_0004465 | |
| Disease | Malignant neoplasm of breast | NCOA6 TBC1D9B MAN2C1 MED14 C4orf50 ZNF318 ARID1A WNK1 PGR SYNE2 FOXM1 SMARCAL1 BCAR1 SIRT1 ARAP3 MTOR DIP2C USP54 SPEN CDH1 | 7.30e-04 | 1074 | 246 | 20 | C0006142 |
| Disease | Dystonia | 7.78e-04 | 86 | 246 | 5 | C0013421 | |
| Disease | Parkinson disease | 7.84e-04 | 22 | 246 | 3 | cv:C0030567 | |
| Disease | skin pigmentation measurement | 1.05e-03 | 137 | 246 | 6 | EFO_0007009 | |
| Disease | Metastatic melanoma | 1.08e-03 | 54 | 246 | 4 | C0278883 | |
| Disease | Profound Mental Retardation | 1.13e-03 | 139 | 246 | 6 | C0020796 | |
| Disease | Mental deficiency | 1.13e-03 | 139 | 246 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.13e-03 | 139 | 246 | 6 | C0025363 | |
| Disease | FEV change measurement, response to zileuton | 1.15e-03 | 25 | 246 | 3 | EFO_0005921, EFO_0007676 | |
| Disease | JT interval | 1.19e-03 | 248 | 246 | 8 | EFO_0007885 | |
| Disease | birth weight, parental genotype effect measurement | 1.19e-03 | 192 | 246 | 7 | EFO_0004344, EFO_0005939 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | BNC2 HIVEP1 NFASC DCC ZKSCAN5 XYLT1 MAGI2 USH2A UTRN SDK1 PRRC2B SGIP1 PHC2 TENM4 ZFHX3 IGSF21 | 1.21e-03 | 801 | 246 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | refractive error, age at onset, Myopia | 1.23e-03 | 193 | 246 | 7 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Schizophrenia | EPHX2 HDAC9 NFASC DCC NDUFS1 MAGI2 DLG1 PLA2G6 GNAS ADNP2 SIRT1 TENM4 CSF2RB MTOR STON2 CALY ATP2A2 | 1.27e-03 | 883 | 246 | 17 | C0036341 |
| Disease | Endometrial Neoplasms | 1.41e-03 | 58 | 246 | 4 | C0014170 | |
| Disease | grapefruit juice consumption measurement | 1.41e-03 | 7 | 246 | 2 | EFO_0010094 | |
| Disease | proactivator polypeptide-like 1 measurement | 1.41e-03 | 7 | 246 | 2 | EFO_0801912 | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 1.41e-03 | 7 | 246 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | Intellectual Disability | STAG1 GON4L QRICH1 DCC GNAS MED13 MED13L COL18A1 MTOR SMARCC2 HTT | 1.42e-03 | 447 | 246 | 11 | C3714756 |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 1.51e-03 | 200 | 246 | 7 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Insulin Sensitivity | 1.59e-03 | 60 | 246 | 4 | C0920563 | |
| Disease | Insulin Resistance | 1.59e-03 | 60 | 246 | 4 | C0021655 | |
| Disease | age-related hearing impairment | 1.69e-03 | 324 | 246 | 9 | EFO_0005782 | |
| Disease | Bilateral Wilms Tumor | 1.78e-03 | 29 | 246 | 3 | C2930471 | |
| Disease | smoking status measurement, Cannabis use, schizophrenia | 1.78e-03 | 29 | 246 | 3 | EFO_0006527, EFO_0007585, MONDO_0005090 | |
| Disease | autism spectrum disorder, schizophrenia | 1.80e-03 | 327 | 246 | 9 | EFO_0003756, MONDO_0005090 | |
| Disease | platelet component distribution width | HDAC9 LIN54 ZMYND8 LRRK2 IRS1 WNK1 LRCH1 LIN9 PRRC2C PLA2G6 GNAS WEE1 TRIM33 COL18A1 LTBR | 1.80e-03 | 755 | 246 | 15 | EFO_0007984 |
| Disease | Retinitis Pigmentosa | 1.82e-03 | 104 | 246 | 5 | C0035334 | |
| Disease | Unilateral agenesis of kidney | 1.88e-03 | 8 | 246 | 2 | C0266294 | |
| Disease | lysosomal Pro-X carboxypeptidase measurement | 1.88e-03 | 8 | 246 | 2 | EFO_0801777 | |
| Disease | caudate nucleus volume | 1.97e-03 | 30 | 246 | 3 | EFO_0004830 | |
| Disease | Large cell carcinoma of lung | 2.37e-03 | 32 | 246 | 3 | C0345958 | |
| Disease | lung cancer (implicated_via_orthology) | 2.40e-03 | 9 | 246 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 2.40e-03 | 9 | 246 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | Pituitary Adenoma | 2.40e-03 | 9 | 246 | 2 | C0032000 | |
| Disease | Malignant tumor of prostate | 2.40e-03 | 9 | 246 | 2 | cv:C0376358 | |
| Disease | Cleft palate with cleft lip | 2.40e-03 | 9 | 246 | 2 | C0158646 | |
| Disease | sphingomyelin measurement | 2.43e-03 | 278 | 246 | 8 | EFO_0010118 | |
| Disease | dyslexia | 2.45e-03 | 162 | 246 | 6 | EFO_0005424 | |
| Disease | non-high density lipoprotein cholesterol measurement | ZHX3 BNC2 HIVEP1 ARID1A MIDEAS SYNE2 SNX8 SORCS2 PLA2G6 PLTP ADNP2 DENND4C UNC5CL EEPD1 | 2.82e-03 | 713 | 246 | 14 | EFO_0005689 |
| Disease | myocardial infarction | 2.83e-03 | 350 | 246 | 9 | EFO_0000612 | |
| Disease | unipolar depression | ZHX3 BNC2 ZNF536 TDRD9 ZMYND8 DCC MAGI2 SYNE2 ALPK3 DAGLA SDK1 ADAMTSL1 SGIP1 PCLO ZHX2 ADGRG6 ARAP3 ZFHX3 ATP2A2 HTT | 2.86e-03 | 1206 | 246 | 20 | EFO_0003761 |
| Disease | neutrophil count | BNC2 HIVEP1 LIN54 ITGA4 ACVRL1 ARID1A ZKSCAN5 LIN9 FAM186A OSBPL1A SGIP1 FLVCR1 VTA1 DCLRE1B SIRT1 ADGRG6 TRIM33 ATF6 RP1L1 YY1AP1 PRORP HTT | 2.93e-03 | 1382 | 246 | 22 | EFO_0004833 |
| Disease | Hyperpotassemia and Hypertension, Familial | 2.98e-03 | 10 | 246 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 2.98e-03 | 10 | 246 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 2.98e-03 | 10 | 246 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 2.98e-03 | 10 | 246 | 2 | C1449842 | |
| Disease | Pseudohypoaldosteronism, Type I | 2.98e-03 | 10 | 246 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 2.98e-03 | 10 | 246 | 2 | C0033805 | |
| Disease | reticulocyte count | BNC2 NCOA6 GATAD2A IRS1 TKTL1 ITGA4 ITGAD MIDEAS KAT2B SYNE2 NFRKB PLA2G6 FLVCR1 ZHX2 BAZ1A EEPD1 OTUD4 CDH1 | 3.10e-03 | 1045 | 246 | 18 | EFO_0007986 |
| Disease | Endometrial Carcinoma | 3.11e-03 | 72 | 246 | 4 | C0476089 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.21e-03 | 291 | 246 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | mean arterial pressure | HDAC9 SIK1 ZNF318 TRIP12 GNAS BAHCC1 SGIP1 BCAR1 ARAP3 ZFHX3 ATP2A2 | 3.32e-03 | 499 | 246 | 11 | EFO_0006340 |
| Disease | Nephroblastoma | 3.34e-03 | 36 | 246 | 3 | C0027708 | |
| Disease | prostate carcinoma | ZBTB38 PIK3C2B SYNE2 PLAG1 FERMT2 COL6A3 ADAMTSL1 LMTK2 SIX1 ZNF341 LMO7 DIP2C INTS4 ZFHX3 RPA1 SPEN | 3.49e-03 | 891 | 246 | 16 | EFO_0001663 |
| Disease | sex interaction measurement, Crohn's disease | 3.61e-03 | 37 | 246 | 3 | EFO_0000384, EFO_0008343 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPVLQQAPTQLLEPL | 161 | Q6ZRG5 | |
| IIFQQELPLSPPSQE | 486 | P60509 | |
| PVQTPARSLVPQVSQ | 2721 | Q96L91 | |
| LITSQQPTPETLPVI | 346 | Q52LR7 | |
| QILNVQLSVPFPALP | 751 | P55198 | |
| LPQDAPTQLVILPSE | 866 | Q9P281 | |
| ENSPEPLSLIQPQDI | 721 | Q8WWN8 | |
| LNVNLNPPIPDIRSS | 466 | P0C6C1 | |
| VLPVNDQPPILTTNT | 1466 | Q6UVK1 | |
| ITPVQSPTNLLTLSP | 336 | A6NCI8 | |
| IPQTSLQAKPVAPQV | 16 | Q5T035 | |
| SRLPIPESQVITINP | 101 | O95336 | |
| RSPSEPQEPLVQDLQ | 491 | P56945 | |
| TQFLPTPQLLTQQVP | 171 | Q9C0J9 | |
| LDPVLQNPLPSQLVF | 546 | Q6ZN30 | |
| PQQTLLTQPAVALPT | 101 | Q8IX12 | |
| SITPLLQTQPQPLLQ | 256 | Q8IX12 | |
| QVDPLASVILPPNLL | 716 | Q86SQ4 | |
| ASVILPPNLLENLSP | 721 | Q86SQ4 | |
| AQVLPPDTLPNRTVT | 71 | Q8IWK6 | |
| RTQATQLPIIPTAQP | 576 | Q9HCU0 | |
| VPAENTVILPTIPQA | 181 | Q12959 | |
| LQPLRATIPFQLQQP | 41 | Q9C073 | |
| ESLPVIIVANEPLQP | 3831 | Q6V0I7 | |
| QASEPVTTQLLGQPP | 1881 | Q96L96 | |
| QTVPISNLQILPGPL | 1141 | Q68CP9 | |
| ESLPALNEQTLPVQP | 1556 | Q8IYW2 | |
| NPQSIALIPPATTEI | 981 | Q9P2G1 | |
| QQTPTIPNRLAADPV | 446 | P37023 | |
| SQPTVVQLQAPGVLP | 236 | P18850 | |
| VQLQAPGVLPSAQPV | 241 | P18850 | |
| RVPQPVQVSPSLLQA | 1791 | Q6UB98 | |
| SPRISVPLIPDSVQQ | 311 | Q9H816 | |
| NPPPLFNEVSATVIQ | 241 | Q86XH1 | |
| VPLTPRVNINTATPA | 131 | Q7L9B9 | |
| QNLQSFPEPLIIPVL | 76 | Q9NRL2 | |
| PINQTVRPGVLPLTQ | 391 | Q6IQ32 | |
| SAQPPLQLSEVNIPL | 581 | O75175 | |
| PLLLEAQSTPFQVTP | 266 | Q86Y37 | |
| VPQDLQLPPSQRAQS | 6 | Q8WWK9 | |
| VLQAPQPKALSQTVP | 176 | Q9H6Z4 | |
| QPQEPTLPFEAVLQN | 176 | Q9Y5P3 | |
| PLLPSPASLQLAQLQ | 81 | Q5T481 | |
| AVNQPLMPLPQTLSL | 646 | Q01804 | |
| IQIQTVGALSPPPSQ | 211 | Q2TAL8 | |
| ISSQATPPLLQPAPQ | 61 | Q6PCD5 | |
| PSIIPQEDPSQQFLQ | 601 | Q96HW7 | |
| GLLQSTELVPPDPQQ | 1771 | Q9HCM3 | |
| VILLDSNPLQSPPAQ | 231 | O75427 | |
| NRVIPTNVPELTFQP | 51 | O00255 | |
| SESQLQPDQPDIPIT | 496 | Q14207 | |
| TPQPTATPTLNQLLT | 286 | O14497 | |
| VNDNTPVITAPPLIN | 556 | Q8TAB3 | |
| NVPNTSLLVNIPQPT | 296 | Q86YP4 | |
| PPPVEQVTLQDLSQL | 131 | Q14296 | |
| PPTQSEVDQLSLPQE | 1576 | P51610 | |
| VPSAPPQNVSLEVVN | 621 | P43146 | |
| ITLDNNPLQSPPAQI | 246 | Q96II8 | |
| IQPNLTNLPPGTVLA | 446 | Q6MZP7 | |
| PLQSPIIDNDPLLGQ | 306 | Q5TKA1 | |
| PANSIIPERLTPTNI | 621 | Q9P2G4 | |
| PSAFVLISQNDIPVP | 281 | Q71F56 | |
| IVPIAPELQPSTSRN | 1571 | Q14676 | |
| EPAPLLLNVTDQILP | 191 | Q86UL8 | |
| RVVAQPSLPAVPQQS | 806 | Q6P4R8 | |
| LPADITQLNNIPPTQ | 1061 | Q3T906 | |
| TSQLGIQTVINPPPV | 376 | Q92831 | |
| ILLNQTPLSTPPNVS | 281 | Q86T24 | |
| IPPELTRLLQQSQDP | 551 | Q96H55 | |
| PAIPSINILQNVTPK | 1591 | Q5HYC2 | |
| ITLVPVDDQPPVLNA | 551 | Q5SZK8 | |
| TQLLILDPPQVPTQL | 1366 | Q8N6G6 | |
| TATLQPRVNLQPAPS | 351 | A6NNH2 | |
| QFIPPQTQTESQLVP | 3866 | Q9Y6V0 | |
| TIALVPPDQPEVQLS | 351 | P55058 | |
| QPEDLSLAVLQPTPQ | 501 | Q9H307 | |
| SQPVPRSVLVLNIPD | 226 | P80217 | |
| RPLSVQQPTALALEP | 791 | Q9Y5F6 | |
| VLSQIVASIQPPQSP | 766 | Q9H792 | |
| QLLGDPPPQQVTQTD | 461 | P39060 | |
| PATIPENAQTVLPQA | 1151 | Q6ZU69 | |
| LPVDNQVPEAFTNPL | 771 | Q5H8C1 | |
| AAPTLVPQQPEQVLS | 891 | Q14005 | |
| PPAVVAQPQALLTTQ | 696 | Q9ULH7 | |
| APAPAQSLQVQAVTP | 31 | Q14863 | |
| IQLPSQSPVEEQSPA | 861 | Q8WWI1 | |
| LLLENNPLQSPPAQI | 261 | Q9Y2L9 | |
| VNPDQPRLTIPISQI | 1841 | Q5S007 | |
| SALVLVQEQPLPEPV | 1126 | Q8IWU2 | |
| LQALQTQLLPQALPP | 741 | Q9UMN6 | |
| QTTIPIPQLPQETQS | 456 | Q9NQV6 | |
| TSLPPGLPTQELLQI | 541 | O94927 | |
| SPKSVSAPQQIINPI | 636 | P35568 | |
| ELTALLNRPNPPDVN | 156 | Q9BXW6 | |
| QQTLIICPPAIQGIP | 621 | Q9H422 | |
| TVPLVTQAPAVQPLQ | 651 | Q9H422 | |
| PLLTNQITLSAPQPV | 731 | Q9H422 | |
| IAASLELNNPVPEQP | 46 | Q9NYZ3 | |
| VLSLPNIILTNGQPT | 171 | Q9BY21 | |
| FLQLTQKTSVPPQEP | 1366 | O60244 | |
| ESVPLAPPQNLTLIN | 1281 | Q9UMZ3 | |
| VETPEITSALNQLPP | 546 | O00750 | |
| QGPPVNQLPLIDTSN | 646 | Q8IV76 | |
| LNFSLVREPIPSPQN | 731 | Q13349 | |
| STPPIVPDIQKNLTQ | 186 | O94913 | |
| QNVELPRNVLVSPTP | 1366 | Q14686 | |
| LPQPVGVPNESQALS | 656 | P06401 | |
| SPGQDIQLIPPLINL | 676 | P06401 | |
| PSIQNELTQPPTITK | 31 | O94856 | |
| QVINIRPITTGNSPP | 26 | P27694 | |
| QEPPAAATSLLLPIQ | 551 | Q8IZD4 | |
| PLPLIFQITPLNVTQ | 951 | P16615 | |
| SLNNQPIPRPDTQEL | 246 | O43313 | |
| PALQVDNVPAPSELL | 231 | Q6ZRC1 | |
| ISSAPVPVEIENLPQ | 421 | Q9HCM4 | |
| SVPINNGPLLSTQPE | 676 | Q05DH4 | |
| QQLFRTPPPELLQTL | 381 | P42858 | |
| TPDPNILLQPTTENI | 251 | Q96ID5 | |
| VQPPEPRDLQISTDQ | 131 | P32927 | |
| QLIQPQFETPLPTLQ | 321 | Q9Y366 | |
| VTGIQLLNTPAPLPT | 216 | P34913 | |
| LPLDIPQASPQQVQR | 261 | A1L0T0 | |
| VPLDQTLPLNVNPAL | 26 | Q9NP55 | |
| SVPLISPLDISQLQP | 26 | Q9NYX4 | |
| SQLQPPLPDQVVIKT | 36 | Q9NYX4 | |
| TIVFSQLPLPSPQET | 71 | O95273 | |
| ILSILDELQLSPQPP | 441 | O75912 | |
| LILQDDIPAPNIPSS | 76 | Q9Y3I1 | |
| LTFATPLQPQSVQRP | 191 | Q96BT3 | |
| DFSSLPALPQQLIQP | 801 | P12111 | |
| ITPLNPLEVPLLNTS | 121 | P00414 | |
| PALAPDQLPQNNTLV | 51 | Q9NVF7 | |
| PVNAAVAQSPQTIPI | 1166 | Q3T8J9 | |
| QSILIPPSELETNPA | 1201 | Q9Y2E4 | |
| APPVRPQNSLAVTDI | 146 | Q5VZ89 | |
| SNLVPPVELANPENQ | 111 | P63092 | |
| QPSQQTTPALVLAPA | 581 | Q8IZC6 | |
| QQLPIISVDNLPPAS | 1831 | Q8IZC6 | |
| PPVLVPNTQNDTNLL | 256 | Q9Y5Y0 | |
| NAMLTQIPPLTAPQI | 331 | O94769 | |
| QIPPLTAPQITSLEL | 336 | O94769 | |
| TSLQPLLPQQPVFVV | 666 | Q9NTJ4 | |
| LQDSAPQPALPQVQI | 326 | Q6PJG2 | |
| RSTEEFPPLQPILQQ | 591 | P13612 | |
| SLLTLQGTLQPEPPQ | 531 | O75578 | |
| VDLTPELIFQQQPLP | 686 | Q9Y4D2 | |
| NQSLVLQPSVKVPLP | 386 | Q08050 | |
| ALVPQVVPSSNLNLP | 261 | Q9UIH9 | |
| LVNVAPEPQLLESSP | 176 | Q3LI81 | |
| LTPQQAQALGIPLTP | 1171 | A6NE01 | |
| IPLTPQQAQELGIPL | 1181 | A6NE01 | |
| LTLQQAQQLGIPLTP | 1231 | A6NE01 | |
| LNPQQAQTLGIPLTP | 1291 | A6NE01 | |
| TPQQAQALGIPLTPQ | 1316 | A6NE01 | |
| LTPQQAQELGIPFTP | 1411 | A6NE01 | |
| IPLTPQQVQALGIPL | 1541 | A6NE01 | |
| PLTPQQAQALGIPLT | 1566 | A6NE01 | |
| LTPQQAQELGIPLTP | 1591 | A6NE01 | |
| SAPLPQSTLAQLVIQ | 451 | Q9UKV0 | |
| LNPDPQLIPEQITTD | 501 | Q96AC1 | |
| VSTPLPLGLQQPQAQ | 631 | Q9NZM4 | |
| LEPEPLPTVTNQIQD | 326 | Q9C0D2 | |
| VQQQSTPVPLISPKR | 536 | Q9ULU4 | |
| SPQPESLRPVNLTQE | 516 | O95487 | |
| PSSRVIQTLQAPPDV | 1161 | Q7Z5N4 | |
| IQTLQAPPDVAPTSV | 1166 | Q7Z5N4 | |
| VFPLLEQLLQQPSSP | 201 | O94829 | |
| VINIIDADLPPNTSP | 611 | P12830 | |
| PVIQLPEQTPLAFDN | 626 | Q12889 | |
| EPVSILQPQTTVNPD | 131 | P51513 | |
| QVPSLSLQFPEQNVP | 511 | Q9Y6K5 | |
| ITTPLQPQATTLPAQ | 1841 | Q6ZRI0 | |
| QPQATTLPAQTLSPV | 1846 | Q6ZRI0 | |
| PNQPIIRIQSIAPSL | 2146 | P42345 | |
| SIPLVFPELDQQLQP | 31 | P57077 | |
| LAPGPPTQVEQLELQ | 206 | Q9BQI9 | |
| PVKPPQAQTLILTQA | 91 | A1L443 | |
| PVKPPQAQTLILTQA | 91 | Q5VZR2 | |
| ALQPPVLSLTQPTQV | 716 | O00268 | |
| IQQPLASNPPEDLNR | 2861 | O75445 | |
| PVSQPQSPAQILKSV | 3241 | P46939 | |
| ELIPSVTNPENLPSL | 666 | Q9UPN9 | |
| PSLRAQVPQFLSPQV | 1106 | Q9HCJ0 | |
| NFTALPLNTVVPPQR | 136 | P43307 | |
| PLNTVVPPQRQATFE | 141 | P43307 | |
| SDLPTPQAIEPQAIV | 31 | Q9Y5X2 | |
| LPNISLDVLQPSFPE | 526 | Q9UKY4 | |
| NPSIPLLPDDILSQI | 2751 | Q8WXH0 | |
| AEINQLTLVPLPTHP | 931 | Q8NDG6 | |
| SILNNPNIPPEVISN | 211 | Q9P2K5 | |
| NQQLLADPLVPPQLT | 676 | P28331 | |
| SSIPPALQIDIPVEQ | 1086 | Q8NE09 | |
| SDRTIPQPPILQLSV | 961 | O95486 | |
| LNSNPELRQLPPVDA | 326 | O43490 | |
| LAQSPPEVPKQQLLS | 126 | Q9NZC9 | |
| NLTAVLLPLNPNLTV | 891 | Q96PQ0 | |
| PSALQQVTVPLPASQ | 2576 | Q9Y520 | |
| QVTVPLPASQLSLPN | 2581 | Q9Y520 | |
| TQFAPQILSQPNLVP | 2726 | Q9Y520 | |
| GQIQLLQPPATSPLL | 336 | Q96LK8 | |
| PLLNLPQVVPTSQVV | 471 | Q8N196 | |
| PALLCPQPQTLVQSV | 386 | A0A0B4J2F2 | |
| PALLCPQPQTLVQSV | 386 | P57059 | |
| IPSSIPHEVPQILIN | 451 | Q96EB6 | |
| SLQPALPQIVATNLP | 16 | P18827 | |
| SPPQSPDQNSVLLLQ | 221 | Q15475 | |
| VTQLPGSSQPAVLQP | 51 | O15127 | |
| LQTAVAQLLPQPLVS | 266 | Q96M53 | |
| PISNPEPQINITTAD | 136 | Q99935 | |
| LERAQPPPISLNNLE | 436 | O60733 | |
| NVNLRPPAQPSDQLV | 616 | O60733 | |
| APSVQVPSPFLLQNQ | 251 | Q9Y6Y8 | |
| QPNLVAPTSQSLITP | 1476 | Q9UHV7 | |
| APVRNTIQLPTQPLN | 106 | O15091 | |
| LVPLQPKTPQQTSAS | 541 | Q8TAQ2 | |
| IPQLPSSPENLVSEI | 321 | Q96KW2 | |
| PQVSQPLREQSEDIP | 641 | Q9NRP7 | |
| LNETLQDVQPSPINP | 316 | Q8WXE9 | |
| NTPEGLRPLTLQVPQ | 641 | P0C7V6 | |
| LDNVVNKQSVSPPIP | 731 | Q66K14 | |
| VPPSTTVLLQSLVQP | 261 | Q99941 | |
| LQDPTELAPQQVPGI | 31 | Q9H2A9 | |
| SLTPPQLATPNLQQF | 136 | Q9ULV3 | |
| LPPQTQDLQDPANTI | 456 | Q6DJT9 | |
| VLNSQNLQPPIIPLF | 856 | Q9Y4G8 | |
| PPTPAQVQNLTLRTQ | 216 | Q8IXK0 | |
| TSAVILQLQPASPPQ | 451 | Q8IXK0 | |
| QVQLPVSLDLPLFPS | 2021 | Q86UP3 | |
| NPVLSLPINPAQVEQ | 876 | Q86Y38 | |
| PQVNINPFTPDSLLL | 231 | P30291 | |
| PPSPLIQTLVQGNIL | 121 | Q9BYN7 | |
| LRPLVQATVPATPEQ | 26 | P47985 | |
| QATVPATPEQPVLDL | 31 | P47985 | |
| TVTPSNQLQGLPLTP | 3271 | Q96T58 | |
| NQLQGLPLTPPVVVT | 3276 | Q96T58 | |
| LQALQNEPIPERSPQ | 176 | Q9NUL3 | |
| LFATISQPLIQPQCP | 646 | A0A1B0GUW6 | |
| QPSSPLVLQVGRPEQ | 801 | Q8IWN7 | |
| ALNLPVITQISQALP | 106 | Q12816 | |
| VPLAPITDPQQLQLS | 6 | P31350 | |
| GSLLTPPPQSVQIEN | 531 | A0PJK1 | |
| TSPNVQPSISQPILT | 1751 | P12270 | |
| SNTIQPTPQTIPAID | 236 | Q9NP79 | |
| PPRNVLSPLNLEEVQ | 366 | Q9BQI5 | |
| LQPPAQTISNAPVSE | 466 | Q9BSA4 | |
| LTQPRSLQQPSFLVP | 476 | O95155 | |
| LPLIPPQSQGFTAIV | 446 | Q93063 | |
| LNGQEEPVSQPTPQL | 46 | Q8IV45 | |
| ILPQSIQLPPGQSLS | 2091 | Q5JSZ5 | |
| GSPNPLDIIQETQVP | 871 | Q6N022 | |
| PLPAPQLTSTVLREN | 1111 | Q8WVM7 | |
| QTTVPALATNQPVPL | 211 | Q68DE3 | |
| APTNQNVIILQPPST | 546 | Q68DE3 | |
| VIIQAANQNPLPLLP | 581 | Q68DE3 | |
| TIPNSQIQEPLLKPS | 1306 | Q68DE3 | |
| LQLAVQTLQMSSPPP | 106 | Q6BDI9 | |
| QSLLLDITPEINPLP | 731 | Q9UBS9 | |
| PILPLINPVITDNGT | 156 | Q9BXA5 | |
| APVLEAGVPQQQSPL | 311 | P36941 | |
| QQSPLDLTREPQLEP | 321 | P36941 | |
| PQTIPIATLLVNPTS | 631 | Q9H869 | |
| QPVQGLVSPLSQAPE | 1216 | O15090 | |
| NINLVPKVPVPLNTT | 251 | Q9Y6X8 | |
| QPASPQNVLPVKSLL | 416 | Q7Z3V4 | |
| VPLAEQTPLTLQSQP | 156 | O15535 | |
| QTPLTLQSQPKEPQL | 161 | O15535 | |
| PVSNLEVNQERSPQP | 286 | Q8NAP3 | |
| VVPSQLPTLLQPVTQ | 891 | Q9H4A3 | |
| LPTLLQPVTQLPSQV | 896 | Q9H4A3 | |
| TNILQLIQSPVTTPL | 131 | Q96QU8 | |
| LQPRPVSQQELVAPA | 321 | Q96K80 | |
| PLPPQLQSLFQEVLQ | 56 | Q53S58 | |
| NVQQLLVVTPPILSS | 651 | Q14669 | |
| QLSLVEADTPTVPPQ | 121 | Q9HAV5 | |
| QSVPQPTITVLNTPL | 381 | Q9H4I2 | |
| IPAAQVPVQVSIPSL | 856 | Q5VUA4 | |
| PTVSATIQAQLQLPP | 761 | P56192 | |
| TIQAQLQLPPPACSI | 766 | P56192 | |
| PQILVTQDLPNQPIC | 1656 | P15822 | |
| LLQVLQQTLPPPVFQ | 106 | Q15388 | |
| QIQTSRNLDPQPPIE | 251 | P51854 | |
| SNSLPINVQVFTLPP | 291 | Q12836 | |
| LTININILLPPQFPQ | 61 | Q8NEZ2 | |
| LEENALPVLQVPSLP | 181 | Q9Y2L8 | |
| LSSPPLATQTVVPLQ | 51 | Q9GZU3 | |
| LLGSQPQPVIPASVI | 171 | O95071 | |
| TPQQKLPQLVSLPSL | 2466 | Q15911 | |
| GTLSQPTSEQPIPLQ | 886 | Q70EL1 | |
| PTSEQPIPLQVLLSQ | 891 | Q70EL1 | |
| QPLRPAPEVTTVQLQ | 821 | Q5EBL2 | |
| LPSIQIVQTLPAVQL | 1041 | Q5EBL2 | |
| NLPPVAVVSPQLQEL | 431 | Q5VV43 | |
| QQQPPVAPAITTEAT | 371 | Q8N8K9 | |
| LPTVPEPAALDQVQQ | 986 | O15069 |